Submitted:
10 November 2026
Posted:
12 November 2026
You are already at the latest version
Abstract
Objective: This article argues, from anatomical and mechanical perspectives, that release of the investing fascia has a plausible mechanistic basis and is testable as an intervention for subtypes of dry eye disease. As defined here, release of the investing fascia refers to mechanical intervention on the anterior cervical connective tissue network rather than transection of a discrete fascial layer. These subtypes respond poorly to conventional therapy centered on tear film hyperosmolarity and inflammation and often coexist with abnormal neck–shoulder posture, forward head posture, or neck stiffness. If an upstream fascial mechanical variable amenable to targeted intervention exists, release of the investing fascia may offer these patients an approach distinct from conventional anti-inflammatory or tear supplementation therapy.The argument proceeds along three lines. First, the anatomical line of evidence: the relationship between the investing fascia and the carotid sheath is not a homogeneous direct cable but a layer-specific composite relationship. Adult cadaveric studies suggest that the investing fascia may not exist as an independent continuous layer and that whether a stable fusion interface forms between the carotid sheath and the pretracheal layer remains histologically controversial. These same studies suggest that the midcervical sheath wall is composed mainly of the superficial layer of the prevertebral fascia and that the anterior sheath wall at the skull base–upper cervical segment is formed by the convergence of a four-layer fascial complex comprising the TVSF, SPF, BPF, and LCF. Accordingly, release of the investing fascia should be understood anatomically as mechanical intervention on the anterior cervical connective tissue network, including the superficial layer of the prevertebral fascia and the four-layer complex at the skull base–upper cervical segment, rather than transection of a single fascial layer.Second, the mechanical line of evidence: the anterior cervical connective tissue network is continuous with or tightly connected to the sheath wall, so abnormal passive tension can be transmitted to the sheath wall through this network. In vivo human studies suggest that the efficiency of transmission from external mechanical input at the neck to the carotid artery region is on the order of 60%–90%. After ultrasound-guided hydrodissection, fascial shear modulus decreases significantly under stretch, providing a measurable mechanical precedent for the upstream step of release leading to tension reduction.Third, the downstream-effect line of evidence: if release reduces the abnormal mechanical constraint on the sheath wall and intrasheath structures, six types of effects can be expected according to the four downstream pathways of H3—increased ocular blood supply, improved venous return, improved lymphatic return, reduced intraocular pressure, reduced sympathetic excitability, and increased vagal excitability. Among these, the physiological chain of sympathetic excitation leading to distal arterial constriction and insufficient blood supply, and the hypothesis chain of release leading to reduced sympathetic tone and improved blood supply, are mechanistically linked. The in vivo experiments by Abe et al. in cats, in which sectioning or stimulation of the cervical sympathetic nerve reversibly altered choroidal blood flow, provide a functional-possibility template for the intermediate step of altered sympathetic tone leading to altered ocular blood flow. However, the species, nature of stimulation, and target limitations of this template mean that it does not constitute evidence of mechanical sensitivity and does not change the evidence grade for H2 or H4.The available clinical indirect evidence—a needle-knife RCT, a network meta-analysis, a single-arm hydrodissection study, and a pilot osteopathic RCT—involves composite interventions, unspecified targets, absence of controls, or mismatched populations and endpoints. It therefore cannot be used for mechanistic attribution, although it may serve as an early signal that release may be accompanied by changes in ocular surface, blood flow, or intraocular pressure. On this basis, this article proposes a testable mechanistic framework. In this framework, release of the investing fascia is the intervention, sheath deformation and ocular surface metrics are primary endpoints, the six types of downstream effects are secondary endpoints, and sham-intervention control plus synchronous measurement of ocular surface PIEZO1/Piezo1 pathway are dual exclusion conditions for attribution. The anatomical and mechanical plausibility of this framework is relatively high, but clinical efficacy has not yet been confirmed by controlled trials with clearly defined targets.
Keywords:
dry eye disease subtypes
; investing fascia release
; carotid sheath
; anatomy
; biomechanics
; intervention mechanism
; testable framework
1. Introduction
1.1. Clinical Problem: A Subtype Not Covered by the Traditional Model
The traditional pathological model of dry eye disease centers on the vicious cycle of tear film hyperosmolarity and inflammation (1,2). In clinical practice, this framework consistently encounters a residual: in some patients, ocular surface signs are disproportionate to the severity of subjective symptoms, and a substantial proportion respond poorly to therapy centered on anti-inflammatory treatment and tear supplementation. At the same time, the co-occurrence of abnormal neck–shoulder posture, forward head posture, or neck stiffness is not uncommon in these patients (3,4). These two observations suggest that dry eye disease, at least in one subtype, may involve an upstream mechanical dimension that has not been systematically incorporated. If this dimension can be safely and target-specifically intervened upon, it may offer these patients an approach distinct from conventional anti-inflammatory or supplementation therapy.
1.2. Why Release of the Investing Fascia: From an Anatomical Gap to an Intervention Hypothesis
A clarification is needed regarding the relationship between the procedural name and the anatomical qualification. This article retains the procedural name "release of the investing fascia." The anatomical analysis in Section 2, however, indicates that its material basis is more likely the anterior cervical connective tissue network, including the superficial layer of the prevertebral fascia and the TVSF/SPF/BPF/LCF complex at the skull base–upper cervical segment, rather than a discrete, continuous fascial layer that can be independently dissected. Throughout this article, any reference to release of the investing fascia should be read together with this anatomical qualification.
In introducing fascial biomechanics into dry eye intervention, the primary question is not whether fascial release can improve the ocular surface but which anatomical pathway makes such intervention possible, and whether that pathway is sufficient to support a functional mechanical coupling. Recent fascial research has redefined fascia as a mechanically sensitive active tissue and stem cell reservoir (5), making abnormal passive tension in the investing fascia contributing to ocular surface dyshomeostasis a biologically plausible candidate proposition. However, between fascial mechanical activity and the neck–eye causal chain there exists an anatomical gap that must be precisely delimited: in what manner the investing fascia and the carotid sheath are connected, and whether that connection is sufficient to support measurable downstream effects of release.
The anatomical work of Miyake et al. (6) and Bond et al. (7) indicates that this connection is not a homogeneous direct cable but a layer-specific composite relationship that is described inconsistently across the literature. Zhang and Lee (8) further showed that no investing fascial layer exists between the sternocleidomastoid and trapezius muscles and that the carotid sheath is directly exposed to subcutaneous tissue through this interval, suggesting that the investing fascia is not a continuous mechanical covering layer on the lateral side of the neck. Nash et al. (9), using sheet plastination and confocal microscopy in adult cadavers, suggested that even in the anterior cervical triangle, the investing fascia in the classic sense—as an independent, continuous fibrous layer—may not exist. Hayashi (10), reporting from the carotid sheath side, found that the common sheath does not fuse with the superficial cervical fascia or the pretracheal layer but often fuses with the visceral fascia to form a thick plate. Adult cadaveric dissection by Shan et al. (11) showed that the superficial layer of the prevertebral fascia is thick and dense and extends directly laterally from the vertebral body to form the anterior, medial, and lateral walls of the carotid sheath; it is the principal component of the sheath and renders the sheath relatively fixed. Schachtel et al. (12) further resolved the anterior carotid sheath at the skull base–upper cervical segment into a composite convergence of four fascial layers: TVSF, SPF, BPF, and LCF. Together, these adult anatomical findings indicate that release of the investing fascia should not be understood as transection of a single independent fascial layer but as mechanical intervention on the anterior cervical connective tissue network, including the superficial layer of the prevertebral fascia and the four-layer complex at the skull base–upper cervical segment. This interpretation provides a more robust anatomical basis for release than does transection of a single fascial layer.
1.3. Purpose and Argument Structure of This Article
The purpose of this article is not to assert that release of the investing fascia has been proven to treat dry eye disease, but to argue, from anatomical and mechanical perspectives, the mechanistic plausibility of this intervention as a treatment for subtypes of dry eye disease and to provide a testable framework that can be falsified item by item. The argument proceeds as follows. Section 2 states the layer-specific anatomical constraints of the investing fascia–carotid sheath relationship. Section 3 presents the H1–H5 core propositions and boundary conditions. Section 4 elaborates three parallel transmission pathways, of which Pathway 2, the carotid sheath hub, is the core. Section 5 deduces four groups of downstream effects and, in Section 5.6, focuses on the mechanism spectrum of release of the investing fascia leading to six types of downstream effects. Section 6 provides evidence grading and falsifiable predictions. Section 7 proposes a four-tier validation framework with release as the intervention and an H2-specific pathway. Section 8 discusses clinical implications and boundaries, and Section 9 addresses limitations and alternative explanations.
1.4. Relationship to the Author's Prior Preprints and the Cervical Instability Hypothesis
The author has previously proposed, in preprint form, a broader integrative framework (13), an intervention-oriented framework anchored to the immediate effects of multi-node minimally invasive release (14), and a narrative review of six-system coupling that uses increased neck circumference as an entry point (15). This article shares with these three works the core motivation that abnormal fascial mechanics of the investing fascia may contribute to some cases of dry eye disease, but its problem formulation differs. This article no longer focuses on broad integration or reverse inference from intervention effects. Instead, it treats release of the investing fascia as the intervention to be argued, concentrates on testing its anatomical and mechanical plausibility, and explicitly identifies H2 as the logically necessary node of the entire chain. This article shares with the cervico-ocular hypothesis proposed by Hauser et al. (4) the node of the carotid sheath as a mechanical hub, but the upstream starting point differs. The Hauser hypothesis takes osseous structural instability as the cause, whereas this article takes abnormal mechanics of the investing fascia and anterior cervical connective tissue network as the cause. The two may superimpose within the same subtype and cannot substitute for each other.
2. Anatomical Basis: Layer-Specific Constraints on Release of the Investing Fascia
2.1. Investing Fascia–Carotid Sheath: Layer Specificity and Literature Controversy
2.1.1. Classic Description and Controversy Over the "Three-Layer Fascial Envelope" Model
The carotid sheath is classically described in anatomy as a fascial structure enclosing the common and internal carotid artery, the internal jugular vein, and the vagus nerve, but the specific fascial origin and attachment pattern of the sheath wall have long been inconsistent in the literature. The systematic review by Bond et al. explicitly states that the fascial composition of the carotid sheath is an unresolved controversy and that the traditional three-layer fascial envelope model has been systematically challenged (7). This means that any line of reasoning that relies on direct anatomical continuity between the investing fascia and the carotid sheath to argue for a release effect must itself have its premises precisely qualified.
2.1.2. Constraints of Miyake et al.'s Fetal Anatomical Data on the Coupling Pathway
The fetal anatomical study by Miyake et al. showed that the carotid sheath is clearly separated from the prevertebral fascial layer but is fused with the pretracheal fascial layer covering the strap muscles (6). This finding constitutes a direct constraint on the anatomical formulation of release: the mechanical effect of releasing the investing fascia to the carotid sheath cannot be described as a homogeneous direct cable. A more reasonable formulation is that tension is indirectly coupled to the sheath wall through intermediate interfaces such as the pretracheal fascia, and that this coupling is layer-specific. This fusion relationship, however, derives from fetal specimens, and its direct extrapolation to adult chronic postural loading conditions carries developmental-stage uncertainty.
2.1.3. Correction of the Anterior Cervical Fusion Interface by Hayashi's Adult Histological Data
In semi-serial sections from 8 sides of 5 adult cadavers, Hayashi (10) reported that the common sheath of the carotid sheath does not fuse with the superficial cervical fascia or the pretracheal layer but often fuses with the visceral fascia to form a thick plate. The common sheath and the prevertebral layer are sometimes interrupted or indistinct, but the vascular adventitia itself is a continuously intact annular structure. This adult histological observation and Miyake et al.'s fetal data constitute a developmental-stage contrast of the same interface: the relationship of sheath–pretracheal layer fusion observed in fetal specimens cannot be directly reproduced in adults as a stable fusion interface. Therefore, the anterior cervical pathway of releasing the investing fascia should be formulated as indirect coupling through the anterior cervical connective tissue network, including intermediate interfaces such as the pretracheal fascia, rather than as reliance on a stable fusion interface directly extrapolated from fetal data. Hayashi's sample size was limited, its common sheath demarcation is not completely equivalent to Miyake's concept of the sheath, and it did not involve mechanical measurements.
2.1.4. Correction of Sheath Wall Composition by Shan et al.'s Adult Anatomical Data
In dissections of 22 formalin-fixed adult cadavers and 6 fresh cadavers, Shan et al. (11) reported that the superficial layer of the prevertebral fascia is thick and dense. It extends directly laterally from the vertebral body to the front of the common carotid artery and internal jugular vein, forming the anterior, medial, and lateral walls of the carotid sheath. When the integrity of the superficial layer of the prevertebral fascia was maintained, medial and lateral mobility of the carotid sheath was markedly restricted. The authors therefore concluded that the prevertebral fascia is the principal component of the carotid sheath and renders the sheath relatively fixed. This finding constitutes an adult–fetal divergence from Miyake et al.'s (6) fetal data that the sheath is clearly separated from the prevertebral fascial layer. It also complements Hayashi's (10) observation that the common sheath does not fuse with the pretracheal layer but fuses with the visceral fascia. For release, this means that if release of the investing fascia is to exert a mechanical effect on the sheath wall, it is more likely to proceed along the anterior cervical connective tissue network. This network includes, in particular, the continuous or tightly connected structures between the superficial layer of the prevertebral fascia and the sheath wall, rather than solely intermediate interfaces such as the pretracheal fascia. Shan et al.'s sample consisted of adult cadavers, the conclusions address sheath wall composition and mobility, and the study did not involve quantitative measurement of mechanical transmission efficiency.
2.1.5. Further Decomposition of Anterior Sheath Wall Composition by Schachtel et al.'s Skull Base–Upper Cervical Anatomy
Shan et al. (11) reported in the midcervical segment that the superficial layer of the prevertebral fascia constitutes the main body of the sheath wall. Based on dissection of 8 cadaveric head sides with high-resolution T1 MRI correlation, Schachtel et al. (12) reported at the skull base–upper cervical segment that the anterior carotid sheath is not a single fascial layer. Rather, it is a composite structure formed jointly by four fascial layers: TVSF, SPF, BPF, and LCF. Among these, the LCF originates from the medial edge of the posterior belly of the digastric muscle, directly covers the front of the internal jugular vein and internal carotid artery, and is continuous with the anterior fascia of the longus capitis. The posterior layer of the LCF extends laterally to cover the posterior aspect of the ICA and IJV but is clearly separated from the more posterior prevertebral fascia. The BPF and LCF are tightly fused in the upper cervical segment and difficult to separate, and this fascial complex appears as a low-signal line on T1-weighted MRI and is thickest directly anterior to the ICA. This finding does not contradict the midcervical report by Shan et al. (11) that the superficial layer of the prevertebral fascia constitutes the main body of the sheath wall. Rather, both point to the same conclusion: sheath wall composition exhibits spatial heterogeneity along the longitudinal axis of the cervical segment. This places more precise requirements on the interface histological sampling in Section 7.1 and the finite element modeling in Section 7.2. Schachtel et al.'s sample comprised 8 cadaveric head sides, and the study focused on the skull base–temporal bone region. Extrapolation to the midcervical segment requires integration with Shan et al.'s (11) data. The study was a purely anatomical and radiological description that did not involve mechanical measurements.
2.1.6. Exclusion of the Lateral Cervical Pathway by Zhang and Lee's Sectional Observations
The review by Bond et al. suggests that the fascial composition of the sheath wall varies across individuals and across the literature (7). Zhang and Lee's thin-sheet plastination sectional study further showed that no investing fascial layer exists between the sternocleidomastoid and trapezius muscles. It also showed that this interval is entirely filled with fat indistinguishable from subcutaneous tissue and that the carotid sheath is directly exposed to subcutaneous tissue through this interval (8). This finding narrows the anatomical scope of application of release of the investing fascia: its mechanical effect cannot be formulated as a continuous covering-layer pathway on the lateral side of the neck but is more likely concentrated in the anterior cervical connective tissue network pathway. This narrowing has been incorporated into the parenthetical qualification in the original text of H2. The review by Bond et al. further suggests that the fascial composition of the sheath wall varies across individuals and across the literature (7), implying that the transmission efficiency after release may itself be one source of individual variation.
2.1.7. Nash et al.'s More Fundamental Constraint on the Continuity of the Anterior Cervical Investing Fascia
Nash et al. (9), based on dissection of 10 adult cadavers, E12 thin-sheet plastination, and confocal microscopy, suggested that in the anterior cervical triangle, the investing fascia in the classic sense—as an independent, continuous fibrous layer—may not exist. Deep cervical potential spaces are directly continuous with subcutaneous tissue. In the upper neck, the strap muscle fascia and bilateral submandibular gland fascia form a dumbbell-shaped fascial sheet, and in the lower neck, no single continuous connective tissue sheet directly spans between the sternocleidomastoid muscles. This finding should not be regarded as a refutation of release of the investing fascia. It should be understood as a requirement to refine the formulation of its material basis. The investing fascia targeted by release may not have as its material basis a discrete fascial layer that can be easily dissected. Rather, its material basis may be the overall mechanical state of the anterior cervical connective tissue network, including the pretracheal fascia, the superficial layer of the prevertebral fascia, the TVSF/SPF/BPF/LCF complex, and other structures. This more cautious formulation, while retaining the core of release, protects the intervention hypothesis from being directly challenged at its root by anatomical controversy. Nash et al.'s sample consisted of adult cadavers, the conclusions mainly address the continuity of fascial layers in the anterior cervical triangle, and the study did not directly measure mechanical transmission efficiency.
2.1.8. Developmental Histological Evidence from Zhao et al. and the Prerequisite of Sheath Wall Responsiveness
The developmental histological study by Zhao et al. (16) showed that across four developmental stages in rabbits, a three-layered fascial architecture consistently appeared around the artery, vein, and vagus nerve within the carotid sheath. The inner fascial layer on the arterial side thickened earliest and formed a dense multilayered fibrous structure, whereas the inner fascial layers on the venous and neural sides were relatively thin. The outer fascial layers of adjacent structures exhibited potential fusion, which the authors interpreted as possibly reflecting extrinsic mechanical interactions from surrounding tissues. The significance of this finding for release is that the fascial architecture of the sheath wall is not mechanically inert at the biological level: it stratifies and thickens during development according to differences in mechanical exposure, and its outer layer is the interface for extrinsic mechanical interactions. Therefore, if release of the investing fascia is effective, its effects should show spatial consistency between the outer fascial fusion region of the sheath wall and the mechanical response characteristics of the inner fascial layers. If the sheath wall is completely unresponsive to mechanical cues, then the release chain lacks an activatable biological receiver from the outset. Zhao et al.'s species was the rabbit, extrapolation to human adult chronic postural loading conditions still requires direct examination of human interface tissues, and the study detected H&E and α-SMA but not Piezo1/YAP.
2.1.9. Core Qualification of This Section: Anatomical Adjacency Does Not Equal Release Efficacy, but Release Leading to Tension Reduction Has a Measurable Precedent
The core qualification of this section is that anatomical adjacency or interlaminar interdigitation does not constitute proof that release of the investing fascia is effective. From sheath–pretracheal layer fusion to release of the investing fascia producing downstream effects with an efficiency sufficient to alter the intrasheath microenvironment, a quantitative gap exists that requires ex vivo mechanical testing and in vivo deformation measurement to fill. The interventional plausibility argued in this article is precisely proposed to address this gap.
It should be added that the upstream step of whether release can mechanically reduce fascial stiffness and stress already has quantitative evidence from a peer-reviewed journal. Nakao et al. targeted fascia with ultrasound-guided hydrodissection and used shear wave elastography to measure the shear modulus of muscle and fascia before and after the intervention, finding that fascial shear modulus decreased significantly under stretch but did not change significantly under relaxation (17). This evidence does not address the investing fascia or the carotid sheath; its sample comprised only 12 cases; the intervention was hydrodissection rather than release of the investing fascia; and the measurement targets were muscle and fascia rather than the anterior cervical connective tissue network. Nevertheless, it transforms the step of release leading to tension reduction from a purely theoretical inference into a proposition with a measurable precedent. What it supports is the upstream mechanical effect of the release procedure; it does not change the core judgments that the cross-layer transmission efficiency of H2 is unknown and that the clinical attribution of H4 is unproven.
2.2. The Neck–Eye Myofascial Continuum: An Auxiliary Pathway Rather Than the Core
2.2.1. Anatomical Prerequisite of Pathway 1 and Its Confirmation at the Review Level
The anatomical prerequisite of Pathway 1 is that the investing fascia extends anteriorly through the galea aponeurotica to the periorbital and periocular soft tissues. The systematic review by Prabu Raja et al. confirms that the deep cervical fascia, the galea aponeurotica, and the fascial sheath of the eyeball constitute a proximal posterior myofascial chain, but its anatomical description differs substantially across the literature, and no reasonable functional interrelationship has yet been established among these structures (18).
2.2.2. Descriptive Inconsistency and Unverified Function
This review-level judgment means that Pathway 1 faces not only the conventional gap from anatomical existence to mechanical transmission but also a prerequisite uncertainty: even the specific course of the continuum has not yet been uniformly described. Therefore, this article does not treat Pathway 1 as the core of the argument for release intervention but lists it as the auxiliary pathway with the lowest level of evidence.
3. Core Propositions and Boundary Conditions
3.1. Proposition Statements
3.1.1. H1: Postural Loading Leading to Fibrosis and Increased Tension in the Investing Fascia and Anterior Cervical Connective Tissue Network
H1 (starting point): Chronic static postural loading may promote fibroblast activation and fibrotic remodeling in the investing fascia and anterior cervical connective tissue network, manifesting as increased collagen deposition, reduced viscoelastic buffering capacity, and increased passive tension. Its principal molecular candidate is the Piezo1–YAP/TAZ axis: in vitro mechanical stretch can upregulate fibroblast Piezo1 and drive activation via YAP (19), and in vivo genetic evidence has demonstrated that the Piezo1–YAP/TAZ axis performs a causal transduction function in myofibroblast-mediated tissue fibrosis (20). Huang et al. provided in vivo pharmacological causal evidence that Piezo1 drives fibroblast activation in connective tissue and fascia-related tissues in an epidural fibrosis model (21). Konishi et al. (22) and Alba et al. (23) detected Piezo1/PIEZO1/2 expression in the human carotid artery region, and Tu SW et al. (24) provided causal analog evidence for fibroblast Piezo1/YAP in mouse articular fascia. He et al. (25), Li et al. (26), and Liao et al. (27) provided functional evidence for the Piezo1–YAP/TAZ axis in human hypertrophic scar, bladder fibroblasts, and human keloid fibroblasts, respectively. Together, these lines of evidence support the Piezo1–YAP/TAZ axis as the principal molecular candidate for H1, but none derives from the investing fascia itself. Whether the investing fascia shares this mechanism remains a proposition to be tested.
3.1.2. H2: Abnormal Tension Cross-Layer Transmission to the Carotid Sheath
H2 (coupling): The abnormal passive tension induced by H1 may be transmitted indirectly, with an as-yet-unquantified efficiency, through the deep cervical interlaminar fascial network and the anterior cervical connective tissue network to the carotid sheath region, altering the mechanical microenvironment of the sheath wall and intrasheath structures. Transmission is primarily via the anterior cervical connective tissue network pathway; the lateral cervical pathway is excluded because the investing fascial layer is incomplete (8). The material basis of the anterior cervical pathway must also consider several anatomical constraints. The investing fascia may not exist as an independent continuous layer (9). Whether a usable fusion interface forms between the carotid sheath and the pretracheal layer in adults is itself histologically controversial (10). The adult sheath wall is composed mainly of the superficial layer of the prevertebral fascia (11), and anterior sheath wall composition at the skull base–upper cervical segment represents a four-layer fascial composite convergence of TVSF/SPF/BPF/LCF with spatial heterogeneity along the longitudinal axis of the cervical segment (12). The developmental histological evidence from Zhao et al. (16) provides a histological prerequisite for H2—that the sheath wall is mechanically responsive. However, this evidence derives from rabbits and did not detect Piezo1/YAP, and it cannot substitute for direct examination of the human interface. In addition to the fibroblast Piezo1–YAP/TAZ axis, the candidate mechanisms linking H2 to downstream inflammatory and autonomic dimensions also include the macrophage PIEZO1–CISD1/IP3R axis (28). They also include evidence of macrophage PIEZO1 mechanoimmune transduction in vascular pathology and inflammatory pain (29,30). All three are parallel candidates for the interface inflammatory dimension and do not change the definition of H2 as centered on mechanical coupling.
3.1.3. H3: Four Groups of Downstream Pathways
H3 (downstream): Altered mechanical microenvironments within the sheath may affect ocular surface homeostasis and intraocular pressure regulation through four overlapping groups of pathways: arterial perfusion, venous return, lymphatic drainage, and autonomic neural regulation. These four groups are expanded in Section 5.6 into six measurable effect types.
3.1.4. H4: Interventional Relevance to Dry Eye Disease Subtypes
H4 (interventional relevance): In dry eye disease subtypes, particularly those with abnormal neck–shoulder posture or sign–symptom dissociation, the chain constituted by H1–H3 may have interventional relevance. That is, if release of the investing fascia can reduce the abnormal tension transmission described by H1 and H2, it may produce measurable downstream effects through the four H3 pathways. This relevance is an upstream modulation superimposed on the local ocular surface mechanical and inflammatory pathways, rather than a replacement for them (1,2). The existing RCTs, network meta-analyses, single-arm studies, and pilot RCTs of cervical intervention provide only indirect clinical signals and cannot be used for mechanistic attribution (31–34). The definition of this subtype must be stratified by age (35–37) and depends on whether the synchronous measurements required by H5 can be implemented.
3.1.5. H5: Testability and the Non-Equivalent Consequences of Falsification
H5 (testability): Each link in H1–H4 can be supported or refuted through synchronous in vivo measurements and controlled intervention studies within the same subject. The falsification consequences of each node are not equivalent: H2 is the logically necessary node, and its negative result is sufficient to invalidate the entire intervention chain, whereas negative results for H1, H3, H4, and the three pathways would respectively weaken the corresponding link or branch but would not necessarily invalidate the entire chain. The testability of H5 already has partial methodological precedents. Controlled loading of deep fascia has in vivo quantitative data (38), and the reliability of posterior cervical fascia SWE has supporting evidence (39,40). The transmission efficiency from external mechanical input at the human neck to the carotid artery region has in vivo order-of-magnitude reference values (41,42). SWE-measurable stiffness reduction after fascial hydrodissection has a precedent (17). However, the first three items do not target the investing fascia itself, and the fourth does not target the specific investing fascia–sheath wall pathway. Therefore, synchronous measurement within the same subject remains a research agenda yet to be realized.
3.2. Boundary Conditions
This framework does not claim to apply to all dry eye disease; tear film hyperosmolarity, inflammation, corneal neuropathic changes, and meibomian gland dysfunction remain the principal mechanisms of dry eye disease (1,2,43). It does not claim unidirectional causality: reverse or bidirectional relationships may well exist between increased fascial tension and ocular surface inflammation or intraocular pressure fluctuation. It does not use the effectiveness of existing interventions as evidence that the mechanism is established: any symptom improvement after fascial release or cervical needle-knife intervention may be contributed by placebo effects, expectation effects, nonspecific autonomic activation, or the broad physiological effects of acupuncture (31–34). It must be distinguished from local ocular surface mechanical transduction pathways. A PIEZO1–NLRP3 pathway exists in the corneal epithelium (1), and a Piezo1–p38–CREB pathway exists in the conjunctival epithelium (2). The cervical mechanical effect claimed for release of the investing fascia is a candidate upstream modulation superimposed on these local pathways. It must be distinguished from the osseous instability hypothesis. Dynamic compression of the carotid sheath caused by abnormal cervical alignment (4) and the layer-specific indirect coupling of the investing fascia and anterior cervical connective tissue network claimed in this framework share the carotid sheath hub but differ in their upstream starting points. The two may superimpose within the same subtype and cannot substitute for each other.
3.3. Relationship to Existing Models
This framework is positioned as an upstream mechanical intervention framework rather than a replacement model. It attempts to answer not whether dry eye disease is driven by inflammation but whether, in some individuals, an upstream fascial mechanical variable exists that can be safely and target-specifically intervened upon, thereby making the ocular surface more likely to enter a stable state. Its value depends on whether it can generate testable predictions that existing models cannot produce.
4. Three Parallel Transmission Pathways
4.1. Pathway 1: The Galea Aponeurotica–Fascial Sheath of the Eyeball Continuum (Auxiliary Pathway)
This pathway hypothesizes that investing fascial tension extends anteriorly through the galea aponeurotica to the periorbital and periocular soft tissues. The review by Prabu Raja et al. confirms the existence of this myofascial chain but simultaneously points out that its anatomical description differs substantially across the literature and that no reasonable functional interrelationship has yet been established among its constituent structures (18). Therefore, this article lists it as the auxiliary pathway with the lowest level of evidence and does not treat it as the core of the argument for release intervention. Any future test of Pathway 1 must first resolve the inconsistency in its anatomical description.
4.2. Pathway 2: The Carotid Sheath Hub Pathway (Core Pathway)
4.2.1. Core Status Derives from Logical Necessity Rather Than Evidence Strength
Pathway 2 is positioned as the core not because its evidence strength is the highest but because it is the most discriminating proposition in the entire intervention chain. If H2 does not hold and the mechanical coupling between the investing fascia, anterior cervical connective tissue network, and carotid sheath is broken, then the downstream effects of release cannot be transmitted to the eye, and the entire intervention hypothesis consequently fails.
4.2.2. Spatial Transmission from the Anterior to the Posterior Sheath Wall
The anatomical particularity of the carotid sheath lies in its being a mechanical microenvironment shared by multiple structures: the internal carotid artery, the internal jugular vein, the vagus nerve, and the cervical sympathetic trunk are adjacent to one another within a confined space. Miyake et al.'s data indicate that in fetal specimens the sheath is fused with the pretracheal fascia and separated from the prevertebral fascia (6). Hayashi's adult histological data suggest that the common sheath does not fuse with the pretracheal layer (10). Shan et al.'s adult anatomical data suggest that the superficial layer of the prevertebral fascia constitutes the anterior, medial, and lateral walls of the carotid sheath (11). Schachtel et al.'s skull base–upper cervical data suggest that the anterior sheath wall is formed by a four-layer fascial composite of TVSF/SPF/BPF/LCF (12). Loading of the anterior sheath wall is therefore better understood as loading of the multilayered fascial composite within the anterior cervical connective tissue that is continuous with or tightly connected to the sheath wall. Zhang and Lee's data indicate that no investing fascial layer exists in the lateral cervical SCM–trapezius interval (8), and Nash et al.'s data suggest that the anterior cervical investing fascia may not exist as an independent continuous layer (9). The review by Bond et al. suggests that the fascial composition of the sheath wall varies across individuals and across the literature (7), implying that the cross-layer transmission efficiency after release may itself be one source of individual variation. Zhao et al.'s (16) developmental histological data further indicate that the inner fascial layers of different intrasheath structures are asymmetric in thickness—thickening earliest on the arterial side and being relatively thin on the venous and neural sides. This asymmetry implies that the mechanical effects produced by release may themselves be non-uniformly distributed within the sheath.
A specific spatial transmission question must be raised here. If release of the investing fascia reduces the abnormal tension exerted by the anterior cervical connective tissue network on the anterior sheath wall, and if what lies immediately against the posterior sheath wall is precisely the cervical sympathetic trunk (44,45), then the downstream effects of release cannot be described broadly as altered loading of the sheath wall. They must confront the following question: how is the mechanical perturbation of the anterior sheath wall transmitted to the sympathetic structures at the posterior sheath wall? Kiray et al. demonstrated that the sympathetic trunk may lie within the sheath and reported its spatial distances from the longus colli and the anterior tubercles of the cervical transverse processes (44). Chen et al. further demonstrated that in most specimens the sympathetic trunk lies immediately against the posterior sheath wall, deep to the prevertebral fascia (45). Taken together, these findings imply that the posterior sheath wall is the most direct anatomical target region for the mechanical effects of release. However, the transmission efficiency and pathway from the anterior wall to the posterior wall remain a link that has not yet been quantitatively measured.
In vivo human studies have already provided order-of-magnitude reference values for the transmission efficiency of external mechanical input at the neck to the carotid artery region. Querry et al., using balloon catheters, reported that the transmission efficiency from external cervical positive and negative pressure to carotid sinus tissue pressure was approximately 89% and 82%, respectively (41). Ludbrook et al., using fluid-filled catheters, reported external pressure transmission efficiencies of approximately 86% for positive pressure and 64% for negative pressure (42). The methodological differences between these two data sets themselves indicate that the measurement instrument can significantly affect readings of transmission efficiency and that transmission efficiency in the negative-pressure direction may be lower. They cannot substitute for direct measurement of the specific pathway of release of the investing fascia leading to sheath wall deformation. They do, however, provide a human in vivo anchor whose pathway is not fully matched, yet whose order of magnitude is referable, for the transmission efficiency required by release.
4.2.3. Population Parameterization of Target Variation
The systematic review and meta-analysis by Park et al. (46), integrating 8 studies and 273 middle cervical ganglia, reported a pooled detection rate of 50.4% (95% CI 34.5–66.4%, I² = 94.9%). It explicitly recorded one variant: the cervical sympathetic trunk adherent to the posterior wall of the carotid sheath. Yin et al.'s (47) anatomical report on 32 Chinese adult cadavers found a middle cervical ganglion detection rate of 28.1%, with mean angles between the cervical sympathetic trunk and the vertebral midline of 11.2° ± 1.8° on the left and 10.3° ± 1.4° on the right. C6–C7 was identified as a high-risk zone for sympathetic trunk injury. Lyons and Mills (48), in neck dissections of 12 cadavers, reported that the sympathetic chain lay within the carotid sheath in 2 cadavers, whereas in the remaining 10 the sympathetic chain could be clearly distinguished from the sheath wall. Taken together, these data indicate that the posterior sheath wall sympathetic target inferred for release of the investing fascia exhibits substantial variation in both presence and position across populations. If this variation is not distinguished, synchronous correlational studies may mix subjects with two different mechanical targets and dilute the effect to the point of non-detection. Struthoff et al.'s (49) immunofluorescence quantification of 17 human carotid arteries provides another layer of reference. Dense tyrosine hydroxylase–positive sympathetic nerve fibers are present at the carotid bifurcation, the fibers gradually approach the lumen along the internal carotid artery segment, and the ICA and ECA segment lies approximately 2.5 mm from the intimal surface. These data support the proposition that sympathetic innervation accessible to mechanical signals exists around the carotid artery, but their dimension is the radial lumen-to-nerve distance rather than the transmural anterior-to-posterior sheath wall distance, and the two must not be conflated when cited.
4.2.4. Molecular Candidates for Cross-Layer Transmission: The Piezo1–YAP/TAZ Axis
Tu et al.'s study provides a direct in vitro mechanistic template: mechanical stretch upregulates fibroblast Piezo1 expression and drives fibroblast activation, proliferation, and migration via the YAP pathway (19). In vivo genetic causal evidence comes from Xu et al.: conditional knockout of Piezo1 in Postn⁺ myofibroblasts significantly inhibited mouse pulmonary fibrosis by blocking YAP/TAZ nuclear localization, and myofibroblast-specific double knockout of Yap/Taz fully reproduced the protective phenotype of Piezo1 knockout (20). The additional pharmacological, histological, and functional evidence enumerated in Section 3.1.1 further shortens the extrapolation span. As noted there, these lines of evidence jointly support the Piezo1–YAP/TAZ axis as the principal molecular candidate for H1, but none derives from the investing fascia itself. From the proposition that the Piezo1–YAP axis has in vivo causality in pulmonary fibrosis to the proposition that release of the investing fascia can alter Piezo1–YAP/TAZ signaling at this interface, immunohistochemistry of interface tissues and in vivo deformation measurement are still required to fill the gap.
4.2.5. Non-Fibroblast Mechanoimmune Pathways: Macrophage PIEZO1
Wei et al., in a pulmonary fibrosis model, demonstrated that increased matrix stiffness activates the CISD1/IP3R axis via macrophage PIEZO1, leading to mitochondrial calcium overload and MPTP opening and driving proinflammatory polarization (28). Atcha et al. demonstrated that Piezo1-mediated mechanotransduction enhances macrophage uptake of oxidized low-density lipoprotein and promotes atherogenesis (29). Shen et al., in an acute gout model, demonstrated that PIEZO1 in tissue-resident macrophages can transduce mechanical stress into inflammatory pain (30). Together, these three lines of evidence indicate that macrophage PIEZO1 can perform mechanoimmune transduction functions in different tissues, including vascular pathology and inflammatory pain. However, their tissues were lung, atherosclerotic plaque, and gouty joint, respectively, none of which involves the carotid sheath or the investing fascia interface. This pathway is parallel to the fibroblast Piezo1–YAP/TAZ axis, and its mechanical exposure profile is highly isomorphic to the hypothesis of release of the investing fascia leading to reduction of abnormal stiffness and tension and then to cross-layer transmission. The starting point in each is abnormal tissue stiffness, the intermediate step in each is PIEZO1 activation in non-fibroblast cells, and the endpoint in each is inflammation or fibrosis. The review by Yang et al. (50) further integrates integrin–FAK, Piezo1, and YAP/TAZ into a core mechanosensing machinery in the pulmonary fibrotic microenvironment and proposes a self-reinforcing loop between SPP1⁺ macrophages and POSTN⁺ fibroblasts. This framework provides a testable loop template for linking H2 to the downstream interface inflammatory dimension, but its tissue context is pulmonary fibrosis, and extrapolation to the investing fascia–carotid sheath interface remains a testable analogy.
4.2.6. Prerequisite Support and Parallel Pathways for Fascial Mechanotransduction
The systematic review by Pirri et al. provides prerequisite support for this chain at the level of tissue biology: fascia constitutes an active mechanobiological hub and stem cell reservoir capable of influencing tissue repair and fibrosis (5). The review simultaneously makes clear that current evidence remains preliminary and that mechanistic human studies are urgently needed. The review by Kirkness and Scarlata proposes that mechanical stress can regulate hyaluronic acid deposition via the Piezo1–Ca²⁺–hyaluronic acid synthase axis, thereby altering the viscoelasticity and remodeling direction of the fascial extracellular matrix (51). The existence of this parallel pathway means that even if future evidence for the Piezo1–YAP/TAZ axis in the investing fascia is negative, this cannot directly refute the higher-order proposition that fascial mechanotransduction participates in remodeling. However, neither review addresses the investing fascia, the carotid sheath, or ocular outcomes, and therefore neither can substitute for the testable propositions of H1 in this article.
4.3. Pathway 3: The Posterior Cervical Myodural Bridge–Intracranial Pressure–Intraocular Pressure Pathway (Auxiliary Pathway)
Li et al.'s animal experiment provides direct causal evidence for the starting link of this chain: in a rat model of suboccipital muscle hyperplasia, intracranial pressure was significantly elevated, whereas after surgical transection of the myodural bridge connection, intracranial pressure decreased accordingly (52). However, the boundaries of this evidence must be precisely annotated. It is a rat model and a specific pathological model, differing significantly from the fascial tension changes caused by chronic forward head posture in humans in terms of mechanical nature and time scale. The experiment covers the myodural bridge–intracranial pressure link, whereas the downstream chain from intracranial pressure to intraocular pressure and then to ocular surface homeostasis lies outside its evidence scope. Therefore, Pathway 3 remains positioned in this article as an auxiliary pathway of low evidence grade and is not treated as the primary test target for the argument for release intervention. Its evidence also serves a methodological function: constraining the distinction between the venous pathway and the myodural bridge–intracranial pressure pathway (52).
5. Downstream Effects and Parallel Mechanisms
The following four groups of downstream effects are developed mainly along Pathway 2, the carotid sheath hub. The downstream mechanisms of Pathway 1 and Pathway 3 remain unclear and are not included in the deduction of this section for the time being. The four groups of effects are not mutually exclusive within an individual, but their weighting combinations differ, and this itself may be a source of the heterogeneity of dry eye disease.
5.1. Arterial Perfusion Dimension
Mechanical compression of the carotid artery or ophthalmic artery branches may reduce ocular perfusion pressure. This node has the strongest evidence among the four groups, but the specific chain of release of the investing fascia leading to reduced intrasheath arterial compression and improved ocular perfusion still lacks synchronous measurement within the same subject. A single-arm feasibility study showed that ultrasound-guided hydrodissection targeting the periarterial fascia, in 13 patients with chronic cervical myofascial pain, was accompanied by a temporary increase in target arterial blood flow (11.2 to 17.2 mL/min) and a decrease in pain scores (33). What this study demonstrates is that a human procedure targeting the periarterial fascia can alter local arterial hemodynamics, not that release of the investing fascia can improve ocular perfusion. Moreover, it is a single-arm design without controls and without ocular outcomes, and it can only serve as hypothesis-generating evidence. The evidence from Atcha et al. (29) and Shen et al. (30) on macrophage PIEZO1 in vascular pathology suggests that periarterial mechanoimmune pathways may participate in vascular wall pathology, but their tissues are not ocular perfusion beds and cannot be directly extrapolated. Therefore, increased ocular blood supply should be positioned as an expected effect of the arterial perfusion dimension. The strength of existing indirect evidence is moderate–low, and the key gap is synchronous measurement within the same subject of investing fascial mechanical parameters, sheath deformation, and ophthalmic artery blood flow. It does not constitute attributional support for H4.
5.2. Venous Return and Intraocular Pressure Dimension
Compression of the internal jugular vein may affect ocular venous return and is associated with elevated intraocular pressure. The evidence grade for this node is moderate–low: evidence of venous mechanical sensitivity exists in humans but has not yet been replicated under conditions of investing fascial mechanical exposure. Li et al. have demonstrated a causal mechanical connection between the myodural bridge and intracranial pressure (52). Therefore, the venous pathway and the myodural bridge–intracranial pressure pathway must be measured and modeled independently when explaining changes in intraocular pressure. The pilot RCT by King et al. reported that a single osteopathic manipulative intervention, comprising myofascial release and cranial osteopathic techniques, produced a short-term intraocular pressure reduction of approximately 1.3–1.6 mmHg in a population with suspected ocular hypertension or glaucoma (n = 16) (34). However, its intervention was composite, its sample size was small, its population did not have dry eye disease, its effect size was small, and its follow-up was short, so it cannot be attributed to release of the investing fascia. The cross-sectional observation by Hauser et al. (3) reported, in 203 patients with chronic ocular symptoms, the coexistence of internal jugular vein narrowing within the carotid sheath, reduced vagus nerve cross-sectional area, optic nerve sheath dilation, and elevated intraocular pressure. The study was cross-sectional in design, had no controls, made no causal inferences, and had no dry eye disease diagnosis. Its cross-sectional area threshold criterion was derived from the study itself and cannot serve as a universal normal or abnormal cutoff. Within this framework, its function is methodological only; the same study is referenced at several later points solely to recall that function, not to re-argue it. It demonstrates that intrasheath structural metrics and ocular metrics can be acquired synchronously within the same subject, a function that is further operationalized in Section 7.3, Human Synchronous Mechanistic Cohort. It does not constitute mechanistic attributional support for H2 or H4.
5.3. Lymphatic and Glymphatic Clearance Dimension
The convergence in the neck of lymphatic drainage from the ocular surface and ocular adnexa and of intracranial glymphatic outflow pathways makes the carotid sheath region a potential bottleneck for fluid clearance. Clapham et al. (53) identified 12 deep cervical lymph nodes adjacent to the internal carotid artery within the carotid sheath in 4 cadavers. Struthoff et al. (49) reported 21 lymph nodes and 13 ganglia around 17 carotid arteries. Keser et al. (54) demonstrated in 81 living humans, using high-resolution MRI, that fluid drainage along the internal carotid artery into cervical lymph nodes is functionally present in vivo. The review by Yan M et al. (55) provides the functional background of the ocular–nasal lymphatic pathway. Together, these lines of evidence indicate that the lymphatic pathway has advanced from structural existence to in vivo functional existence, but alteration of drainage function under mechanical conditions after release of the investing fascia has not been measured at all. Clapham and Struthoff were cadaveric histological studies, and Keser was a baseline-state MRI study without mechanical exposure. Therefore, this node remains the lowest evidence grade in this framework.
5.4. Autonomic Neural Dimension
Mechanical stimulation of the cervical sympathetic trunk may cause ocular vasoconstriction and intraocular pressure fluctuation, whereas compression of the vagus nerve may be associated with autonomic imbalance. The anatomical targets and target variation of this dimension have been detailed in Section 4.2. Kiray (44) and Chen (45) provided progressive spatial relationships of intra- and post-sheath localization. Park (46) and Yin (47) quantified the presence and positional variation of the middle cervical ganglion. Lyons and Mills (48) provided original anatomical observations of intra-sheath sympathetic chain variation, and Struthoff (49) provided quantitative histological distances for periarterial sympathetic nerves. At the in vivo level, vagus nerve cross-sectional area can be measured by ultrasound. Oura et al. (35) reported age-specific reference values in a community-dwelling elderly population (right 1.3 mm², left 1.2 mm²). Bedewi et al. (36) reported intra-sheath baseline values in healthy adults (right 2.1 mm², left 1.9 mm²), and Fisse et al. (37) reported pooled reference values from a systematic review (2.2 mm², 95% CI 1.5–2.9). The three cannot be directly pooled or substituted for one another: Oura's elderly population values are significantly lower than those of the latter two, suggesting that measurement location and age may jointly contribute to the difference. Fisse's pooled value is of higher methodological grade, but its conclusion of no significant effect of age is in tension with Oura's age-related decline. Cross-sectional area itself is not a direct marker of sheath wall mechanical effects; it provides a morphological baseline, not functional or mechanical evidence. The cross-sectional observation by Hauser et al. (3) reported the coexistence of internal jugular vein narrowing within the carotid sheath, reduced vagus nerve cross-sectional area, optic nerve sheath dilation, and elevated intraocular pressure. Its observational design, however, cannot infer causality and cannot prove that these structural abnormalities are driven by investing fascial mechanical coupling. The value of this study should be limited to a feasibility precedent for synchronous measurement of intrasheath structures and ocular metrics within the same subject, for reference in Section 7.3. It does not constitute support for the causal chain of the autonomic neural dimension. The autonomic neural pathway remains the link among the four groups of downstream effects with the least clear directionality and the greatest difficulty in excluding placebo and nonspecific effects.
5.5. Parallel Mechanisms and Attribution Exclusion Conditions
5.5.1. Corneal PIEZO1–NLRP3 and Conjunctival Piezo1–p38–CREB
Lian et al.'s study demonstrated that in the corneal epithelium, tear hyperosmolarity acts as a mechanical stimulus to activate the NLRP3 inflammasome via PIEZO1, and that PIEZO1 inhibition can prevent this activation and rescue dry eye–related phenotypes (1). Fukuoka et al. further demonstrated that mechanical stress can activate the p38 MAPK–CREB pathway via Piezo1 in conjunctival epithelial cells, upregulating proinflammatory factors such as IL-6 and promoting neutrophil infiltration (2). Together, these two findings indicate that local mechanical–inflammatory transduction on the ocular surface exists not only in the cornea and not only through NLRP3: corneal PIEZO1–NLRP3 and conjunctival Piezo1–p38–CREB constitute two independent parallel pathways. Their independent existence constitutes a key constraint on H4. Even if release of the investing fascia is ultimately shown to affect the ocular surface, these ocular surface pathways exist independently and are core nodes of the classic hyperosmolarity–inflammation loop of dry eye disease. The systematic review by Shen et al. further incorporates Piezo1/2-mediated mechanical and osmotic stimuli and pathways such as p38 MAPK/CREB and the NLRP3 inflammasome into an ocular surface ion channel framework (43).
5.5.2. Peripheral Reference for Mechanical Signals of Downstream Target Organs
Mo et al., using shear wave elastography, reported that lacrimal gland stiffness in patients with visual display terminal–associated dry eye disease was significantly higher than in healthy controls (Emean 11.06 ± 1.26 kPa vs 7.54 ± 1.27 kPa, P < 0.001). They also reported that Emean was significantly positively correlated with subjective dry eye symptom scores but not significantly correlated with TBUT or the Schirmer test (56). This signal indicates that a mechanical dimension quantifiable by SWE exists at the level of the downstream target organ in dry eye disease and that this dimension is correlated with symptoms rather than with conventional tear film metrics. This finding echoes, at the phenomenological level, the sign–symptom dissociation subtype of interest in H4 of this article. However, several annotations are required. The study was cross-sectional in design and cannot infer whether increased lacrimal gland stiffness is a cause, a consequence, or an accompanying phenomenon. The measurement target was the lacrimal gland rather than the investing fascia or the carotid sheath. The study was single-center with a limited sample size. Therefore, it does not address the cross-layer coupling proposition of H2, does not change the evidence grade of the release intervention hypothesis, and cannot be used for cervical mechanical attribution in H4.
5.5.3. Definition of the Dual Attribution Exclusion Conditions
The RCT by Zhang and Liu (31), the network meta-analysis by Yan et al. (32), the single-arm interventional study by Hiroki et al. (33), and the pilot RCT by King et al. (34) will be detailed in Section 7. Taken together with these studies, the attribution constraint can be stated more precisely as the dual attribution exclusion conditions. To support the cervical mechanical attribution of release of the investing fascia leading to ocular surface improvement, two classes of competing explanations must be excluded simultaneously: local ocular surface mechanical–inflammatory pathways (1,2) and nonspecific effects of acupuncture, placebo, or composite intervention in neck- or fascia-related interventions (31–34). The former requires synchronous measurement of tear osmolarity and ocular surface PIEZO1/Piezo1 pathway metrics, covering corneal/conjunctival and NLRP3/non-NLRP3 dimensions, whereas the latter requires sham-intervention control and blinding, as well as explicit specification of the specific anatomical target of the intervention in future studies. If either is missing, attribution does not hold.
5.6. Downstream Effect Spectrum of Release of the Investing Fascia: The Core Section of the Intervention Argument
This section focuses on the downstream effects that may accompany release of the investing fascia. A positioning statement must first be provided: no standardized operational definition of investing fascia release exists in the current literature. The multi-node minimally invasive release reported in the author's prior preprint (14) is a composite procedure, and the needle-knife RCT by Zhang and Liu (31) is also a composite intervention; neither can be equated with a single investing fascia release. Therefore, the six types of effects discussed in this section—increased ocular blood supply, improved venous return, improved lymphatic return, reduced intraocular pressure, reduced sympathetic excitability, and increased vagal excitability—should all be read as the effect spectrum expected according to the four H3 downstream pathways if H2 holds. They should not be read as a list of therapeutic effects already achieved by release of the investing fascia in humans. For clarity of mapping, each of the four H3 groups corresponds to one or more of the six effects. The arterial perfusion pathway corresponds to increased ocular blood supply. The venous return pathway corresponds to improved venous return and, in part, to reduced intraocular pressure. The lymphatic drainage pathway corresponds to improved lymphatic return. The autonomic neural pathway corresponds to reduced sympathetic excitability, increased vagal excitability, and, in part, to reduced intraocular pressure. The six effects are therefore not six independent pathways but a re-description of the four H3 groups at the level of expected measurable outcomes.
Before the six types of effects are developed item by item, an upstream mechanical anchor must first be provided. Nakao et al. targeted fascia with ultrasound-guided hydrodissection and used shear wave elastography to quantitatively measure the shear modulus of muscle and fascia before and after the intervention. They found that fascial shear modulus decreased significantly under stretch but did not change significantly under relaxation, and they accordingly concluded that hydrodissection reduced tissue stress in the fascia under load (17). This study does not address the investing fascia, the carotid sheath, or dry eye disease; its intervention was hydrodissection rather than release of the investing fascia; and its measurement targets were muscle and fascia rather than the anterior cervical connective tissue network. Nevertheless, it demonstrates, using quantitative data published in a peer-reviewed journal, that the upstream step of targeted fascial release can mechanically reduce fascial stiffness and stress under load and that this step is measurable.
5.6.1. Increased Ocular Blood Supply
If H2 holds, reduced intrasheath arterial compression and improvement in ocular perfusion pressure or ophthalmic artery flow parameters can be expected. The closest available human indirect evidence comes from the single-arm study by Hiroki et al. (33): ultrasound-guided hydrodissection targeting the periarterial fascia, in 13 patients with chronic cervical myofascial pain, was accompanied by a temporary increase in target arterial blood flow (11.2 to 17.2 mL/min) and a decrease in pain scores. What this study demonstrates is that a human procedure targeting the periarterial fascia can alter local arterial hemodynamics, not that release of the investing fascia can increase ocular blood supply. Moreover, it is a single-arm design without controls and without ocular outcomes, and it can only serve as hypothesis-generating evidence. The evidence from Atcha et al. (29) and Shen et al. (30) on macrophage PIEZO1 in vascular pathology suggests that periarterial mechanoimmune pathways may participate in vascular wall pathology, but their tissues are not ocular perfusion beds and cannot be directly extrapolated. Therefore, increased ocular blood supply should be positioned as an expected effect of the arterial perfusion dimension. The strength of existing indirect evidence is moderate–low, and the key gap is synchronous measurement within the same subject of investing fascial mechanical parameters, sheath deformation, and ophthalmic artery blood flow. It does not constitute attributional support for H4.
5.6.2. Improved Venous Return
If H2 holds, reduced internal jugular vein compression and improved ocular venous return can be expected. The cross-sectional observation by Hauser et al. (3) provides the methodological precedent characterized in Section 5.2 and operationalized in Section 7.3; as noted there, it cannot serve as attributional evidence for the expected effect of this dimension. The pilot RCT by King et al. (34) reported a short-term intraocular pressure reduction of approximately 1.3–1.6 mmHg after a composite osteopathic manipulative intervention (n = 16), which may indirectly suggest improved venous return. However, the intervention was composite, and the population had suspected ocular hypertension or glaucoma rather than dry eye disease, so it cannot be attributed to release of the investing fascia. Therefore, improved venous return should be positioned as an expected effect of the venous return dimension. The strength of existing indirect evidence is moderate–low, and the key gap is synchronous controlled measurement of release of the investing fascia, IJV cross-sectional area and blood flow, and ocular venous return metrics, which must also be modeled independently from the myodural bridge–intracranial pressure pathway (52).
5.6.3. Improved Lymphatic Return
If H2 holds, improved peri-sheath lymphatic drainage and glymphatic clearance can be expected. The available evidence falls into three tiers. Clapham et al. (53) identified 12 deep cervical lymph nodes adjacent to the internal carotid artery within the carotid sheath in 4 cadavers, and Struthoff et al. (49) reported 21 lymph nodes and 13 ganglia around 17 carotid arteries. Keser et al. (54) demonstrated in 81 living humans, using high-resolution MRI, that fluid drainage along the internal carotid artery into cervical lymph nodes is functionally present in vivo. The review by Yan M et al. (55) provides the functional background of the ocular–nasal lymphatic pathway. Together, these lines of evidence indicate that the lymphatic pathway has advanced from structural existence to in vivo functional existence, but alteration of drainage function under mechanical conditions has not been measured at all. Therefore, improved lymphatic return should be positioned as an expected effect of the lymphatic and glymphatic clearance dimension. The strength of existing evidence is low, and the key gap is direct measurement of lymphatic drainage function under mechanical exposure conditions.
5.6.4. Reduced Intraocular Pressure
If H2 holds, a reduction in intraocular pressure can be expected. However, this expectation must be strictly distinguished from the myodural bridge–intracranial pressure pathway. Li et al. (52) have demonstrated that the myodural bridge can bidirectionally alter intracranial pressure. Therefore, changes in intraocular pressure cannot be attributed by default to internal jugular vein compression, and the venous pathway and the myodural bridge–intracranial pressure pathway must be measured and modeled independently. The cross-sectional observation by Hauser et al. (3) provides the methodological precedent characterized in Section 5.2 and operationalized in Section 7.3; as noted there, it cannot serve as attributional evidence for the expected effect of this dimension. The pilot RCT by King et al. (34) reported a short-term intraocular pressure reduction of approximately 1.3–1.6 mmHg after a composite osteopathic manipulative intervention (n = 16). However, the intervention was composite, the sample size was small, the population did not have dry eye disease, and the follow-up was short. Therefore, reduced intraocular pressure should be positioned as an expected effect of the venous return dimension, with the caveat that any observed change must be distinguished from the potential contribution of the myodural bridge–intracranial pressure pathway (52). The strength of existing indirect evidence is moderate–low, and the key gap is synchronous measurement of release of the investing fascia, sheath deformation, and intraocular pressure, with simultaneous acquisition of surrogate indicators of the intracranial pressure pathway to exclude confounding (52).
5.6.5. Reduced Sympathetic Excitability
Physiologically, sympathetic excitation can cause distal arterial constriction in the innervated region, thereby producing local insufficiency of blood supply; in the eye, mechanical stimulation of the cervical sympathetic trunk can cause ocular vasoconstriction and intraocular pressure fluctuation. Therefore, if release of the investing fascia does reduce the abnormal mechanical stimulation to which the sympathetic structures of the posterior sheath wall are subjected, reduced sympathetic excitability and attenuated ocular vasoconstrictive tone can be expected, thereby forming a mechanistic link with increased ocular blood supply. However, this chain remains a testable inference yet to be examined.
The available literature provides morphological reference values (35–37) and anatomical constraints (44–49), and one in vivo animal experiment provides a functional-possibility template for the intermediate link of altered sympathetic tone leading to altered ocular blood flow. Abe et al., using laser Doppler flowmetry to measure choroidal blood flow in 32 anesthetized cats, reported that partial choroidal blood flow increased continuously after sectioning of the cervical sympathetic nerve. Electrical stimulation of the peripheral end of the sympathetic nerve elicited two opposite responses—decreased blood flow and increased blood flow—among which the decreased response was considered to be caused by enhanced activity of vasoconstrictor fibers in the choroidal capillaries (57). The value of this evidence lies in demonstrating that sympathetic activity status can reversibly alter ocular blood flow under in vivo conditions. However, its species, nature of stimulation, measurement targets, and directional limitations mean that it cannot be extrapolated as evidence of mechanical sensitivity of the investing fascia or carotid sheath and does not change the evidence grade of H2 or H4. Its complete boundaries are given in Section 9.5. In summary, reduced sympathetic excitability should be positioned as an expected effect of the autonomic neural dimension. The strength of existing indirect evidence is low–moderate—strong anatomical constraints but weak in vivo functional evidence derived only from an animal template—and the key gap is synchronous measurement of sympathetic functional indicators and investing fascial mechanical parameters.
5.6.6. Increased Vagal Excitability
If H2 holds, increased vagal excitability and improved parasympathetic tone can be expected. The available evidence consists mainly of morphological reference values for vagus nerve cross-sectional area. Oura et al. (35) reported right 1.3 mm² and left 1.2 mm² in a community-dwelling elderly population. Bedewi et al. (36) reported intra-sheath right 2.1 mm² and left 1.9 mm² in healthy adults, and Fisse et al. (37) reported a pooled reference value from a systematic review of 2.2 mm² (95% CI 1.5–2.9). The three are inconsistent with respect to age effects, and the absolute cross-sectional area values vary widely across the literature. The cross-sectional observation by Hauser et al. (3) provides the methodological precedent characterized in Section 5.2 and operationalized in Section 7.3; as noted there, its threshold criterion was derived from the study itself, and vagus nerve degeneration is a cross-sectional-area-threshold inference rather than functional verification, so it cannot serve as attributional evidence for the expected effect of this dimension. Therefore, increased vagal excitability should be positioned as an expected effect of the autonomic neural dimension. The strength of existing indirect evidence is low–moderate—morphological baseline present, functional evidence absent—and the key gap is synchronous measurement of vagal functional indicators and investing fascial mechanical parameters, with age stratification (35–37).
5.6.7. Attribution Constraints of the Six-Pathway Spectrum and Linkage to Validation
The six types of effects described above are not mutually exclusive within an individual, and their weighting combinations differ, which may itself be a source of the heterogeneity of dry eye disease. However, none of the six can be attributed to release of the investing fascia on the basis of existing indirect evidence alone. To support this attribution, the dual attribution exclusion conditions defined in Section 5.5.3 must be satisfied simultaneously. The first condition is sham-intervention control with blinding to exclude nonspecific effects of acupuncture, placebo, or composite intervention (31–34). The second condition is synchronous measurement of tear osmolarity and ocular surface PIEZO1/Piezo1 pathway metrics to exclude the independent contribution of local ocular surface mechanical–inflammatory pathways (1,2). In addition, the anatomical target of the intervention must be explicitly limited to the anterior cervical connective tissue network, and analyses must be stratified by age (35–37), with concurrent collection of cervical structural variables to distinguish the two upstream explanations of osseous instability versus fascial mechanics (4). If conditions permit, imaging-based stratification of the relationship between the cervical sympathetic trunk and the sheath wall should be performed to incorporate the target variation reported by Park et al. (46), Yin et al. (47), and Lyons and Mills (48).
6. Evidence Grading and Falsifiable Predictions
6.1. Ranking of Evidence Levels
This article uses a five-level system: very low (anatomical adjacency or theoretical inference only, with no direct functional data); low (indirect human observations or cross-tissue or cross-species mechanistic analogies, but the target tissue has not been measured); low–moderate (human histological data or single-arm human signals in or near the target region, but without controls or without direct measurement of the target tissue); moderate–low (controlled human signals or systematic-review-level anatomical constraints, but with mismatches in population, endpoint, or target); and moderate (controlled human evidence for the target tissue or target endpoint). It should be noted that low–moderate in this article is lower than moderate–low, and this ranking is ordered by degree of target tissue absence rather than by literal sequence: low–moderate emphasizes that the target tissue has not been measured, whereas moderate–low emphasizes that controlled signals exist but with mismatches. Readers should not interpret these labels by literal intuition.
6.2. Narrative Summary of H1–H5 and the Three Pathways
The evidence for H1 comprises eight categories. These are: an in vitro fibroblast mechanical stretch template (19); an in vivo genetic causal precedent (20); in vivo pharmacological evidence in epidural fibrosis (21); histological anchors in human carotid plaque and the carotid sinus and carotid body (22,23); a causal analogy in mouse articular fascia (24); evidence in human fibrotic fibroblasts and sustained loading (25–27); and a systematic-review-level premise (5) together with background on the Ca²⁺–hyaluronic acid parallel pathway (51). The current strength is low–moderate, and the shared gap is that none derives from the investing fascia itself.
The evidence for H2 comprises layer-specific anatomical constraints (6,7,8,9,11,44,45); an adult histological interface correction (10); adult sheath wall composition evidence (11,12); a developmental histological prerequisite for the sheath wall (16); target variation parameters (46–49); and molecular extrapolation. The strength is low, and the key gaps are that cross-layer transmission efficiency is unknown, the anterior-to-posterior sheath wall pathway has not been quantified, and synchronous measurement within the same subject is lacking. For the transmission efficiency from external mechanical input at the human neck to the carotid artery region, an in vivo order-of-magnitude reference already exists (41,42), as detailed in Section 4.2.2, but its pathway is not fully matched to H2. SWE-measurable stiffness reduction after fascial hydrodissection also has a precedent (17), but this precedent does not target the investing fascia or the carotid sheath. The macrophage PIEZO1–CISD1/IP3R axis (28), PIEZO1-mediated macrophage oxLDL uptake (29), and macrophage PIEZO1 inflammatory pain transduction (30) are candidate mechanisms linking H2 to downstream inflammatory and autonomic dimensions, rather than molecular templates for the mechanical coupling of H2 itself.
Pathway 2 is homologous to H2, and its rating is low–moderate (indirect), whereas H2 itself is low. The difference between the two arises because the objects rated differ in scope. Pathway 2 includes auxiliary anatomical constraints, molecular extrapolation, and order-of-magnitude references for transmission efficiency beyond H2, whereas the core proposition of H2, cross-layer transmission efficiency, remains low. The two do not constitute a contradiction. Pathway 1 has only systematic-review-level anatomical confirmation, descriptive inconsistency, and unverified function (18), and its strength is very low. Pathway 3 has animal causal evidence (52), and its strength is low–moderate for the starting link only; species and model extrapolation are difficult, and the downstream chain is unverified.
Among the four groups of downstream effects, arterial perfusion has a single-arm human signal but no ocular outcomes (33), and its strength is moderate–low. The venous return and intraocular pressure dimension has human mechanical sensitivity, a pilot RCT (34), and in vivo synchronous observation (3), and its strength is moderate–low. The lymphatic and glymphatic clearance dimension has intrasheath lymph node histology (53), peri-sheath lymph node counts (49), in vivo MRI evidence of drainage along the internal carotid artery into cervical lymph nodes (54), and functional background on ocular–nasal lymphatics (55), and its strength is low. The autonomic neural dimension has several sources of evidence: intrasheath variation (44), fascial–sympathetic trunk relationships (45), middle cervical ganglion detection rate and positional variation (46,47), original anatomical observations of intra-sheath sympathetic chain variation (48), perivascular sympathetic nerve quantification (49), cross-sectional area reference values (35–37), in vivo synchronous observation (3), and an in vivo animal functional template (57). Its strength is moderate–low. Among these, (57) provides only a functional possibility that sympathetic activity alteration leads to ocular blood flow alteration, and does not constitute evidence of mechanical sensitivity (see Section 5.6.5 and Section 9.5 for details). The six-pathway spectrum in Section 5.6 has an overall evidence grade of very low: although the four H3 groups carry moderate–low to low ratings individually, the six effects are conditional on H2, and this additional conditional step lowers the overall grade below that of any single group.
The evidence for H4 comprises inference, parallel-mechanism constraints (1,2), indirect RCT (31), network meta-analysis (32), single-arm study (33), pilot RCT (34), cross-sectional observation (3), and age-stratification constraints (35–37). Its strength is low. None of the five clinical signals can be used for attribution, and subtype definition depends on implementation of H5. H5 itself is not assigned a strength grade. Its methodological anchors include achievable deep fascial pressure (38), posterior cervical fascia SWE reliability (39,40), cross-sectional area reference values (35–37), human in vivo order-of-magnitude references for transmission efficiency from external mechanical input at the neck to the carotid artery region (41,42), and the precedent of SWE-measurable stiffness reduction after fascial hydrodissection (17).
6.3. Falsifiable Predictions
First, if the elasticity and tension parameters of the investing fascia in the anterior cervical region are not significantly correlated with carotid sheath deformation within the same subject, then the core coupling relationship of H2 does not hold. Second, if Piezo1 expression in the investing fascia or peri-sheath interface tissue is not associated with mechanical loading, or if the fibroblast activation phenotype remains unchanged after YAP pathway blockade, then the molecular basis of H1 is weakened (19–27). Third, if, in the dry eye subtype with postural abnormalities, the explanatory power of cervical fascial mechanical parameters for the variance in ocular surface metrics is lower than that of tear hyperosmolarity and ocular surface PIEZO1/Piezo1 pathway parameters, then the subtype attribution of H4 needs to be narrowed (1,2). Fourth, if sham intervention and true fascial release do not differ in immediate changes in ocular metrics, then the mechanical attribution of immediate effects is challenged. Fifth, if the anatomical description of the neck–eye myofascial continuum has still not been unified by independent studies, then Pathway 1 is not testable (18). Sixth, if the bidirectional changes in intracranial pressure observed in animal experiments cannot be reproduced in humans when the mechanical state of the myodural bridge is altered, then the starting link of Pathway 3 is substantially challenged (52). Seventh, if, after controlling for tear osmolarity and ocular surface PIEZO1/Piezo1 pathway metrics, the ocular effects of cervical intervention disappear or do not differ from those of sham intervention, then the cervical mechanical attribution of H4 is substantially challenged (1,2,31–34). Eighth, if, after age stratification, the association between cervical mechanical parameters and ocular surface metrics disappears or is significantly attenuated, then the subtype definition of H4 needs to reconsider the role of age as a confounding variable (35–37). Ninth, if, after controlling for cervical structural variables, the association between investing fascial mechanical parameters and ocular surface metrics disappears, then the fascial attribution of H4 needs to reconsider the possibility of osseous instability as a confounding or alternative explanation (3,4). Tenth, consider a controlled intervention–response study with a clearly defined target. If release of the investing fascia fails to simultaneously alter sheath deformation and at least one downstream effect listed in Section 5.6, or if such an effect does not differ from that of sham intervention, then the causal attribution of release of the investing fascia to the six-pathway spectrum is substantially challenged.
7. Validation Framework: A Four-Tier Agenda With Release as the Intervention and an H2-Specific Pathway
This section includes a four-tier validation agenda, Tier 1 to Tier 4, and, in Section 7.5, a dedicated phased validation pathway for the H2 coupling proposition. The four tiers address, respectively, interface histology, ex vivo mechanics and computational simulation, a human synchronous mechanistic cohort, and a controlled intervention–response study. Section 7.5 is a dedicated operationalization pathway for the single node of H2; its phase divisions partially overlap with, but do not correspond one-to-one to, the four-tier agenda, and the specific correspondence is explained at the beginning of Section 7.5.
7.1. Tier 1: Interface Histology
Piezo1, YAP/TAZ, fibrosis markers, and nerve terminal markers should be detected at the investing fascia–carotid sheath transmission interface, including the anterior cervical connective tissue network, the pretracheal fascia, the superficial layer of the prevertebral fascia, and the TVSF/SPF/BPF/LCF complex at the skull base–upper cervical segment. The key comparison is not presence versus absence of expression but whether expression exhibits spatial consistency along a mechanical-loading-related gradient. Candidate molecular endpoints are as follows. The Piezo1–YAP/TAZ axis (19–27) is the principal candidate, and the Ca²⁺–hyaluronic acid parallel pathway (51) is a mandatory co-endpoint. The macrophage PIEZO1–CISD1/IP3R axis (28), PIEZO1-mediated macrophage oxLDL uptake (29), and macrophage PIEZO1 inflammatory pain transduction (30) serve as parallel candidates for the interface inflammatory dimension. The detection scope should be consistent with the anterior cervical connective tissue network defined in the parenthetical qualification in the original H2 statement. The lateral cervical SCM–trapezius interval is excluded from interface sampling at this tier because the investing fascial layer is incomplete (8). The anterior cervical region should also take into account the anatomical constraints indicated by Nash et al. (9), Hayashi (10), Shan et al. (11), and Schachtel et al. (12). Sampling should extend to the pretracheal fascia, the superficial layer of the prevertebral fascia, and each layer of the TVSF/SPF/BPF/LCF complex, rather than being limited to a single dissectable independent fascial layer or an assumed stable fusion interface.
7.2. Tier 2: Ex Vivo Mechanics and Computational Simulation
Ex vivo testing should quantify the viscoelastic parameters of each layer of the deep cervical fascia and the sheath wall and should quantify cross-layer shear and tensile transmission efficiency, with particular attention to the anterior-to-posterior sheath wall transmission pathway. On this basis, a fluid–structure interaction finite element model should be established to simulate changes in sheath wall deformation and intrasheath pressure distribution after release of the investing fascia. The value of simulation lies in providing quantitative predictions that can be tested by in vivo measurement, rather than in proving the hypothesis. Model boundaries should be consistent with the anterior cervical connective tissue network defined in the parenthetical qualification in the original H2 statement. The intrasheath fascial layer asymmetry reported by Zhao et al. (16) should be incorporated as one of the geometric parameters for modeling. The anatomical constraints indicated by Nash et al. (9), Hayashi (10), Shan et al. (11), and Schachtel et al. (12) should be treated as one source of uncertainty in model geometry and interface parameters. Human in vivo transmission efficiency data (41,42) can serve as an external order-of-magnitude reference for interpreting the transmission coefficients obtained from simulation. The reduction in shear modulus under stretch after fascial hydrodissection reported by Nakao et al. (17) can serve as a mechanical reference for the boundary conditions modeling release, but cannot be used directly as a model input parameter.
7.3. Tier 3: Human Synchronous Mechanistic Cohort
Investing fascial elasticity in the anterior cervical region, carotid sheath deformation, ophthalmic artery flow parameters, intraocular pressure, and tear film metrics should be measured synchronously within the same subject and the same time window, with forward head angle and neck circumference serving as proxy variables for postural loading. The primary analysis is mediation analysis: whether fascial mechanical parameters exert a statistical mediating effect between postural loading and ocular surface or intraocular pressure metrics. This tier must synchronously measure tear osmolarity and ocular surface PIEZO1/Piezo1 pathway–related metrics to distinguish cervical coupling from local ocular surface mechanisms (1,2). It must also perform age-stratified analysis (35–37) and must measure and model the venous pathway and the myodural bridge–intracranial pressure pathway separately (52). In addition, it must concurrently collect cervical structural variables (4). Where feasible, it should perform imaging-based stratification of the relationship between the cervical sympathetic trunk and the sheath wall to incorporate the target variation reported by Park et al. (46), Yin et al. (47), and Lyons and Mills (48). The study by Hauser et al. was cross-sectional in design, had no controls, had no dry eye disease diagnosis, and made no causal inference. Nevertheless, its approach of synchronously acquiring internal jugular vein cross-sectional area, vagus nerve cross-sectional area, optic nerve sheath diameter, and intraocular pressure within the carotid sheath in living humans (3) provides an observational precedent. This precedent supports both the endpoint combination and the operational feasibility of synchronous measurement within the same subject at this tier. The methodological value of this precedent is independent of the invalidity of its causal attribution. The precedent demonstrates that this set of endpoints can be acquired within the same time window. It does not demonstrate that a causal chain exists among these metrics, nor does it change the core judgments that the cross-layer transmission efficiency of H2 is unknown and that the clinical attribution of H4 is unproven.
In the measurement of investing fascial elasticity, the standardized pressure-loading paradigm established by Pires et al. can provide a citable methodological starting point. The study quantified in 43 adults that the mechanical pressure required to reach the deep cervical fascia from the body surface is approximately 6 N/cm² and is not significantly affected by subcutaneous fat thickness or mechanical sensitivity (38). This reference value provides a reproducible starting point for mechanical loading before shear wave elastography measurement, but its measurement target is the transmural pressure from the body surface to the deep fascia, rather than the passive tension of the fascia itself. Liao et al. reported intra-rater reliability ICC 0.63–0.89 and inter-rater reliability ICC 0.54–0.82 in 16 young healthy adults (39); Zandi et al. reported test–retest reliability ICC(3,1) ≥ 0.90 for posterior cervical fascial stiffness in 30 participants (40). However, the measurement targets of both studies were the posterior cervical fascia rather than the investing fascia, and the reliability of investing fascial SWE still requires independent validation. The study by Nakao et al. (17) further suggests that SWE can be used to detect changes in shear modulus under stretch after fascial hydrodissection, providing a methodological precedent of measurable change before and after intervention for SWE measurement in Phase 1 and Phase 4.
7.4. Tier 4: Controlled Intervention–Response Study With Release as the Intervention
The randomized controlled trial by Zhang and Liu divided 84 patients with dry eye disease into three groups: needle-knife plus acupuncture plus artificial tears, acupuncture plus artificial tears, and artificial tears alone. The trial reported that the combined needle-knife group was superior to the other two groups in tear secretion, tear film breakup time, corneal staining, and symptom scores, with a total effective rate of 94.4% (31). This trial provides an early clinical signal that cervical region intervention may be accompanied by improvement in ocular surface metrics. However, its composite intervention design, the difficulty of blinding invasive procedures, and the multiplicity of needle-knife mechanisms make it impossible to distinguish fascial mechanical coupling, nonspecific autonomic activation, broad acupuncture effects, and expectation effects. The network meta-analysis by Yan et al. included 30 RCTs and 2,514 patients and reported that fascia release acupuncture combined with acupuncture ranked best for both tear secretion and tear film breakup time (32). However, the analysis did not specify the specific anatomical target of fascia release, and all interventions were acupuncture-type procedures. The single-arm feasibility study by Hiroki et al. showed that in 13 patients with chronic cervical myofascial pain, ultrasound-guided hydrodissection targeting the periarterial fascia was accompanied by a temporary increase in target arterial blood flow and a decrease in pain scores (33). However, it was a single-arm design without ocular outcomes. The pilot RCT by King et al. provided a controlled signal with intraocular pressure as a direct endpoint: a single composite osteopathic manipulative intervention produced a short-term intraocular pressure reduction of approximately 1.3–1.6 mmHg in a population with suspected ocular hypertension or glaucoma (n = 16) (34). However, its intervention was composite, its sample size was small, and its population did not have dry eye disease. The author's prior preprint (14) used the immediate effects of multi-node minimally invasive release as a clinical anchor. Its intervention-oriented three-pathway parallel structure, however, cannot substitute for the sham-intervention control and parallel-mechanism exclusion requirements of this tier. Nakao et al. (17) used SWE to demonstrate that fascial shear modulus decreases significantly under stretch after hydrodissection, providing a quantitative precedent that release procedures can mechanically alter fascial properties. However, its target was muscle and fascia rather than the investing fascia, and it did not involve ocular endpoints.
Combined with the dual attribution exclusion conditions defined in Section 5.5.3, future Tier 4 studies must simultaneously satisfy both conditions: sham-intervention control with blinding to exclude nonspecific effects of acupuncture, placebo, or composite intervention, and synchronous measurement of tear osmolarity and ocular surface PIEZO1/Piezo1 pathway metrics to exclude the independent contribution of local ocular surface mechanical–inflammatory pathways (1,2). If either is missing, attribution does not hold. In addition, studies should prespecify the primary endpoints of sheath deformation and ocular surface metrics, explicitly define the anatomical target of the intervention, and perform age-stratified analysis (35–37), while concurrently collecting cervical structural variables (4). If conditions permit, imaging-based stratification of the relationship between the cervical sympathetic trunk and the sheath wall should be performed. Such studies involve invasive procedures, and the difficulty of ethical approval and the feasibility of a sham intervention design must be fully justified at the protocol stage.
7.5. Phased Validation Pathway for the H2 Coupling Proposition
Current evidence for H2 remains at the level of anatomical constraints, adult histological interface correction, adult sheath wall composition evidence, developmental histological prerequisite for the sheath wall, target variation parameters, molecular extrapolation, and methodological anchors, and direct human measurement within the same subject is still lacking. To advance H2 from a testable inference to a proposition tested by human measurement, it is recommended to proceed in the following four phases, and a negative or infeasible result at a prior phase should prevent the next phase from being launched blindly.
The relationship between this section and the four-tier agenda in Section 7.1, Section 7.2, Section 7.3 and Section 7.4 must first be explained. This section is a dedicated operationalization pathway for the single node of H2, and its phase divisions partially overlap with, but do not correspond one-to-one to, the four-tier agenda. Phase 1 (SWE reliability) is a prerequisite methodological condition for the measurement of investing fascial elasticity in Section 7.3, Tier 3, and does not replace the interface histology of Section 7.1, Tier 1. Phase 2 corresponds to Section 7.2, Tier 2; Phase 3 corresponds to Section 7.3, Tier 3; and Phase 4 corresponds to Section 7.4, Tier 4. Therefore, this section is not titled direct human evidence, because Phase 1 is a methodological reliability study and Phase 2 is ex vivo and computational simulation, neither of which is direct human evidence.
7.5.1. Phase 1: Investing Fascial SWE Reliability Study
Phase 1 should report the intra-rater and inter-rater ICC, SEM, MDC, and Bland–Altman plots for investing fascial SWE in healthy adults and in subgroups with chronic neck pain or dry eye symptoms. It should also explicitly specify the measurement location, probe angle, and loading paradigm. The anatomical constraints indicated by Nash et al. (9), Hayashi (10), Shan et al. (11), and Schachtel et al. (12) should also be considered. The loading paradigm may reference the transmural pressure calibration of Pires et al. (38). The apparent-value correction issue for SWE measurement of thin-layered tissues (58) should also be considered, and the measurement target should be formulated as the overall stiffness of the anterior cervical connective tissue network. The method by which Nakao et al. (17) used SWE to detect changes in shear modulus before and after fascial hydrodissection can serve as a methodological reference for measurable change before and after intervention in Phase 1. A negative or low-reliability result in Phase 1 means that subsequent correlational studies cannot be interpreted, and the human testing agenda for H2 should be suspended or the measurement protocol redesigned.
7.5.2. Phase 2: Ex Vivo Mechanics and Finite Element Feasibility Simulation
In Phase 2, after Phase 1 confirms measurability, ex vivo testing should quantify the viscoelastic parameters of each layer of the deep cervical fascia and the sheath wall and should quantify cross-layer shear and tensile transmission efficiency, with particular attention to the anterior-to-posterior sheath wall transmission pathway. A fluid–structure interaction finite element model should then be established. The core output of Phase 2 is not to prove H2 but to provide quantitative predictions that can be tested by in vivo measurement. If simulation shows that the sheath wall deformation caused by a release-induced tension change within the physiological range is below the resolution of current ultrasound, then the human correlational study in Phase 3 is not interpretable. Modeling should incorporate the intrasheath fascial layer asymmetry reported by Zhao et al. (16) and should treat the anatomical constraints indicated by Nash et al. (9), Hayashi (10), Shan et al. (11), and Schachtel et al. (12) as one source of uncertainty in model geometry and interface parameters. Human in vivo transmission efficiency data (41,42) can serve as an external order-of-magnitude reference for interpreting the transmission coefficients obtained from simulation. The reduction in shear modulus under stretch after fascial hydrodissection reported by Nakao et al. (17) can serve as a mechanical reference for the boundary conditions modeling release, but cannot be used directly as a model input parameter.
7.5.3. Phase 3: Synchronous Correlation Cohort Within the Same Subject
After Phases 1 and 2 have been passed, Phase 3 should synchronously measure investing fascial SWE stiffness, carotid sheath deformation, ophthalmic artery flow parameters, intraocular pressure, and tear film metrics within the same subject and the same time window. The craniovertebral angle and neck circumference should serve as proxy variables for postural loading, while cervical structural variables are concurrently collected. The primary analyses are partial correlation and mediation analysis. After controlling for age, BMI, neck circumference, and cervical structural variables, the analyses will test whether investing fascial parameters are significantly correlated with sheath deformation. They will also test whether investing fascial parameters exert a statistical mediating effect between postural loading and sheath deformation or ocular surface metrics. This phase must synchronously measure tear osmolarity and ocular surface PIEZO1/Piezo1 pathway metrics (1,2) and must perform age-stratified analysis (35–37). It must also measure and model the venous pathway and the myodural bridge–intracranial pressure pathway separately (52). Where possible, it should perform imaging-based stratification of the relationship between the cervical sympathetic trunk and the sheath wall. If Phase 3 shows that investing fascial parameters are not significantly correlated with sheath deformation, or that the mediating effect is not significant, or that the association disappears after controlling for cervical structural variables, then the core coupling relationship of H2 does not hold. The entire intervention chain is then broken.
7.5.4. Phase 4: Controlled Intervention–Response Study With a Clearly Defined Target
Phase 4 should be initiated only after Phase 3 shows a significant correlation or mediating effect. The intervention should be limited as far as possible to the investing fascia–carotid sheath interface, with sham-intervention control and blinding of both subjects and outcome assessors, and with synchronous measurement of sheath deformation, ocular metrics, tear osmolarity, and ocular surface PIEZO1/Piezo1 pathway metrics. If Phase 4 shows no difference between the true intervention and sham intervention in sheath deformation or ocular metrics, then the mechanical attribution of release is substantially challenged. If the true intervention alters sheath deformation and is accompanied by changes in ocular metrics whereas the sham intervention shows no such effect, then release of the investing fascia gains human causal support. The six types of downstream effects listed in Section 5.6 can serve as the prespecified secondary endpoints for this phase, but the attribution of these secondary endpoints must still satisfy the dual attribution exclusion conditions. The relationship among the four phases is serial rather than parallel. If Phase 1 is not passed, Phase 3 is not interpretable. If Phase 2 shows an effect below the measurement resolution, Phase 3 should not be launched. If Phase 3 shows no correlation, Phase 4 should not be initiated. This serial structure itself is the operationalization of the testability of H5.
8. Clinical Implications and Research Boundaries
8.1. Clinical Implications: A Mechanical–Postural Dimension in Phenotypic Stratification
If the core chain of this framework is partially supported in the future, its clinical implications lie mainly not in immediately promoting treatment of dry eye with fascial release or needle-knife. They lie in incorporating a measurable mechanical–postural dimension into the phenotypic stratification of dry eye disease. Current dry eye trials and clinical pathways almost never routinely collect neck–shoulder posture or cervical fascial mechanical parameters. If these variables are explanatory in some subtypes, a preliminary stratification index combination could include the following: investing fascial stiffness measured by shear wave elastography; carotid sheath deformation, if technically feasible; forward head angle, measured as the craniovertebral angle; neck circumference; cervical structural variables, to distinguish the two upstream explanations of osseous instability versus fascial mechanics (3,4); age-stratification variables (35–37); conventional tear film metrics and tear osmolarity; and ocular surface PIEZO1/Piezo1 pathway–related metrics. If conditions permit, an imaging-based classification of the relationship between the cervical sympathetic trunk and the sheath wall should also be included. This combination is a clinically operable subset of the synchronous measurement agenda in Section 7, Tier 3, rather than a separate independent list. The cross-sectional observation by Hauser et al. (3), the trial by Zhang and Liu (31), the network meta-analysis by Yan et al. (32), the single-arm study by Hiroki et al. (33), and the pilot RCT by King et al. (34) can be regarded as phenomenological-level precedents for this research direction. Among them, the function of the Hauser et al. study (3) should be limited to a methodological precedent for the endpoint combination for synchronous measurement, rather than mechanistic evidence. However, their mechanistic nonspecificity, the ambiguity of intervention targets, the absence of controls in design, or the mismatch of populations and endpoints precisely indicate a constraint. Future clinical studies cannot use symptom improvement after cervical intervention, local blood flow change, small intraocular pressure reduction, or coexistence of carotid sheath structural abnormalities and ocular symptoms as mechanistic evidence. Rather, fascial mechanical parameters, sheath deformation, ocular perfusion, ocular surface PIEZO1/Piezo1 pathway metrics, and tear osmolarity must be incorporated into the same research framework. The anatomical target of the intervention must also be clearly defined, and the dual attribution exclusion conditions must be satisfied simultaneously.
8.2. Research Boundaries
The boundary of this framework is not whether release is effective but under what evidence conditions efficacy can be claimed. The negative boundaries of this framework are summarized in three categories.
(1) It does not claim that release of the investing fascia has already achieved the six types of downstream effects in humans—increased ocular blood supply, improved venous return, improved lymphatic return, reduced intraocular pressure, reduced sympathetic excitability, and increased vagal excitability. Nor does it claim that carotid sheath deformation has been proven to cause changes in vagal function, or that the boundary of dry eye disease subtypes has been clearly delineated by existing evidence.
(2) It does not claim that any cross-species, cross-tissue, or cross-model molecular or mechanical evidence can be directly extrapolated to the human investing fascia–carotid sheath interface. Such extrapolation includes, but is not limited to, the following: (a) extrapolation of the Piezo1–YAP axis from pulmonary fibrosis, epidural fibrosis, human carotid plaque, the carotid sinus and carotid body, mouse articular fascia, human skin scar, bladder fibroblasts, or human keloid fibroblasts to the investing fascia (20–27); (b) extrapolation of macrophage PIEZO1 evidence to the investing fascia–sheath interface (28–30); (c) applicability of the Ca²⁺–hyaluronic acid parallel pathway to the investing fascia (51); (d) extrapolation of the cat electrical stimulation and section experiments of Abe et al. (57) to the mechanical sensitivity of the investing fascia or carotid sheath; (e) extrapolation of the transmission efficiency data of Querry et al. (41) or Ludbrook et al. (42) to the tension transmission efficiency after release of the investing fascia; (f) extrapolation of the reduction in shear modulus after fascial hydrodissection reported by Nakao et al. (17) to the mechanical effects after release of the investing fascia; and (g) extrapolation of the fetal data of Miyake et al. (6) or the rabbit data of Zhao et al. (16) to adult human interlaminar fusion relationships. Specific extrapolation limitations are given in Section 4.2, Section 9.1 Section 9.2 and Section 9.5.
(3) It does not claim that existing clinical indirect evidence, cross-sectional observations, or the osseous instability hypothesis can prove a causal relationship between carotid sheath structural abnormalities and ocular metrics. Specifically, it does not claim the following: (a) that the RCT of Zhang and Liu (31), the network meta-analysis of Yan et al. (32), the single-arm study of Hiroki et al. (33), or the pilot RCT of King et al. (34) supports the core mechanism of this framework; (b) that Hauser et al. (3) or the cervico-ocular hypothesis (4) proves a causal relationship between carotid sheath structural abnormalities and ocular metrics; (c) that the rat experiment of Li et al. (52) can be directly extrapolated to human neck–eye mechanical coupling; or (d) that Clapham et al. (53), Struthoff et al. (49), Keser et al. (54), or Yan M et al. (55) proves lymphatic drainage dysfunction under mechanical conditions. Specific design limitations are given in Section 9.8 and Section 9.9 and Section 9.11.
The specific literature and item-by-item limitations involved in these three categories of boundaries have been annotated in Section 4.2, Section 5.5.3 and Section 5.6.7, Section 9.1, Section 9.2, Section 9.3, Section 9.4, Section 9.5, Section 9.6, Section 9.7, Section 9.8, Section 9.9, Section 9.10 and Section 9.11, and are not repeated here. What this article claims is merely that, from anatomical and mechanical perspectives, release of the investing fascia has a plausible mechanistic basis for intervening in dry eye disease subtypes, and that this mechanism can be tested by a measurement agenda that is falsified in a phased manner.
9. Limitations and Alternative Explanations
9.1. Cross-Layer Transmission Efficiency and Anterior-to-Posterior Sheath Wall Spatial Transmission
Cross-layer transmission efficiency and anterior-to-posterior sheath wall spatial transmission are the most fragile quantitative nodes. Miyake et al.'s data indicate that in fetal specimens the sheath is fused with the pretracheal layer and separated from the prevertebral layer (6). Hayashi's (10) adult histological data further suggest that the common sheath does not fuse with the pretracheal layer. Shan et al.'s (11) adult anatomical data suggest that the superficial layer of the prevertebral fascia constitutes the anterior, medial, and lateral walls of the carotid sheath, and Schachtel et al.'s (12) skull base–upper cervical data suggest that the anterior sheath wall is formed by a four-layer fascial composite of TVSF/SPF/BPF/LCF. These lines of evidence jointly require that loading of the anterior sheath wall targeted by release be understood as loading of the multilayered fascial composite within the anterior cervical connective tissue that is continuous with or tightly connected to the sheath wall. Bond et al. (7), Zhang and Lee (8), and Nash et al. (9) further narrow the available anatomical pathways. Although Zhao et al.'s developmental histological evidence provides a prerequisite for the mechanical responsiveness of the sheath wall, its species is the rabbit (16). The progressive anatomical evidence of Kiray and Chen indicates that the sympathetic trunk lies immediately against the posterior sheath wall (44,45). Park et al. (46), Yin et al. (47), and Lyons and Mills (48) further reported the detection rate of the middle cervical ganglion, positional variation, and intra-sheath sympathetic chain variation, and Struthoff et al. (49) provided quantitative histological data on periarterial sympathetic nerves. However, there are currently no in vivo or ex vivo data at all on the transmission efficiency and pathway from anterior wall loading to the posterior wall sympathetic structures. The human in vivo data of Querry et al. (41) and Ludbrook et al. (42), as noted in Section 4.2.2, provide an order-of-magnitude reference for the transmission efficiency of external cervical mechanical input to the carotid artery region, but their pathway is not fully matched to the pathway required for release of the investing fascia. The SWE data of Nakao et al. (17) provide an upstream mechanical precedent for release leading to reduction in fascial shear modulus under stretch, but their target is muscle and fascia rather than the investing fascia. The animal in vivo functional template of Abe et al. (57) is described in Section 5.6.5 and Section 9.5 and does not change the judgment of the quantitative gap in this section.
9.2. Species and Tissue Extrapolation of Molecular Mechanisms
The species, tissue, model, and endpoint limitations of each line of evidence have been annotated item by item in Section 4.2, and their shared gap is that none derives from the investing fascia itself. Whether investing fascial fibroblasts share the phenotype and mechanotransduction characteristics of Postn⁺ myofibroblasts has not been tested at all. Neither Pirri et al. (5) nor Kirkness and Scarlata (51) addressed investing fascial tissue. The macrophage PIEZO1 evidence of Wei et al. (28), Atcha et al. (29), and Shen et al. (30) derives from mouse pulmonary fibrosis, atherosclerosis, and acute gout models, respectively, none of which involves the carotid sheath or the investing fascia interface. The tissues of He et al. (25), Li et al. (26), and Liao et al. (27) were human skin hypertrophic scar, bladder, and keloid, respectively, none of which is the investing fascia.
9.3. Risk of Parallel Mechanism Confounding and the Dual Attribution Exclusion Conditions
The local ocular surface mechanical–inflammatory pathways demonstrated by Lian et al. (1) and Fukuoka et al. (2) mean that any mechanical–inflammatory signal observed in dry eye patients may be entirely driven by tear hyperosmolarity. The ocular surface ion channel review by Shen et al. (43) further indicates that corneal PIEZO1–NLRP3 and conjunctival Piezo1–p38–CREB are not isolated findings but standard components of Piezo channel inflammatory mechanisms on the ocular surface. The RCT by Zhang and Liu (31) used a composite intervention design. The network meta-analysis by Yan et al. (32) left intervention targets ambiguous. The single-arm study by Hiroki et al. (33) was uncontrolled and reported no ocular outcomes. The pilot RCT by King et al. (34) used a composite intervention, had a small sample, enrolled a non-dry-eye population, and used a short-term intraocular pressure endpoint. Together, these design features mean that any symptom improvement, local blood flow change, or small intraocular pressure reduction after a fascia-related intervention may be contributed by acupuncture, placebo, or composite intervention nonspecific effects. Any of these changes may also be attributable to natural fluctuation. Together, these two classes of competing explanations—local ocular surface pathways and nonspecific intervention effects—constitute the dual attribution exclusion conditions, both of which are indispensable.
9.4. Anatomical Uncertainty of Pathway 1
The review by Prabu Raja et al. indicates that the anatomical description of the neck–eye myofascial continuum differs substantially across the literature and that no reasonable functional interrelationship has yet been established among its constituent structures (18). Before the anatomical premises of this continuum are uniformly described, Pathway 1 is not testable.
9.5. Autonomic Neural Dimension: Morphological Evidence Is Not Equivalent to In Vivo Mechanical Evidence
The fascial–sympathetic trunk spatial relationships reported by Kiray et al. and Chen et al. derive from cadaveric dissection (44,45). The middle cervical ganglion detection rate, positional variation, and intra-sheath sympathetic chain variation reported by Park et al. (46), Yin et al. (47), and Lyons and Mills (48) likewise derive from cadaveric dissection or anatomical studies. The detection rates of Park and Yin differ substantially, with Park et al. showing extremely high heterogeneity (I² = 94.9%) and the sample of Lyons and Mills comprising only 12 cadavers. The nerve quantification of Struthoff et al. (49) derives from cadaveric carotid arteries with a mean age of 85 years, most with atherosclerosis. The cross-sectional area reference values of Oura, Bedewi, and Fisse derive respectively from an elderly population, a single-center healthy adult population, and a pooled systematic review, and the three are inconsistent with respect to age effects (35–37). The cross-sectional observation by Hauser et al. reported the coexistence of carotid sheath structural abnormalities and ocular metrics in living humans (3). However, it had no controls, made no causal inference, and had no dry eye disease diagnosis, and it cannot prove that mechanical sensitivity sufficient to alter autonomic neural function exists in in vivo tissues. The methodological precedent function of the Hauser et al. study (3) has been explained in Section 7.3, and this section does not treat it as evidence of in vivo mechanical sensitivity.
The in vivo animal experiment of Abe et al. (57) provides a functional template for altered sympathetic activity leading to altered choroidal blood flow, but its boundaries must be fully annotated. The species was the cat. The stimulation was either direct electrical stimulation or surgical sectioning, rather than chronic low-amplitude mechanical tension. The measurement target was choroidal blood flow, rather than ophthalmic artery blood flow, retinal blood flow, or ocular surface metrics. Electrical stimulation elicited two opposite responses—decreased blood flow and increased blood flow—and the mechanism of the increase response remains unresolved. Sample and era limitations mean that it cannot serve as high-grade evidence. Therefore, this study can only be positioned as a functional-possibility template for the intermediate link of the H3 autonomic neural pathway and cannot substitute for in vivo evidence of mechanical sensitivity of the human carotid sheath, nor does it change the evidence grade of H2 or H4.
9.6. Animal Experiment Extrapolation of Pathway 3
The bidirectional causal evidence of Li et al. on the myodural bridge–intracranial pressure relationship derives from a rat model of suboccipital muscle hyperplasia (52). Species differences, the pathological nature of the model, and the time scale all differ from chronic postural loading in humans, and the experiment did not involve the downstream chain from intracranial pressure to intraocular pressure to the ocular surface.
9.7. Applicability of Methodological Anchors
The 6 N/cm² pressure required to reach the deep cervical fascia reported by Pires et al. derives from 43 healthy adults (38), describes the transmural pressure from the body surface to the deep fascia, and cannot be equated with the passive tension or stiffness of the investing fascia itself. The SWE reliability data reported by Zandi et al. and Liao et al. both targeted the posterior cervical fascia (39,40), which is not the same structure as the investing fascia. The thin-layer SWE correction framework of Sadeghi and Cortes (58) has not been validated in the investing fascia or the anterior cervical region. The transmission efficiency data of Querry et al. (41) and Ludbrook et al. (42) were obtained using balloon catheters and fluid-filled catheters, respectively. The difference between the two itself indicates that the measurement instrument can significantly affect readings of transmission efficiency. Although the SWE data of Nakao et al. (17) provide a quantitative precedent for release leading to reduction in shear modulus under stretch, their sample comprised only 12 cases, their intervention was hydrodissection, and their target was muscle and fascia rather than the investing fascia.
9.8. Mechanistic Nonspecificity and Design Limitations of Clinical Indirect Evidence
The RCT by Zhang and Liu (31) involved a composite intervention and was difficult to blind. The network meta-analysis by Yan et al. (32) did not specify the intervention target and consisted entirely of acupuncture-type procedures. The single-arm study by Hiroki et al. (33) had a sample of only 13 cases, no controls, and no ocular outcomes. The pilot RCT by King et al. (34) had a sample of only 16 cases, used a composite osteopathic manipulative intervention, enrolled a population with suspected ocular hypertension or glaucoma rather than dry eye disease, achieved an intraocular pressure reduction of only approximately 1.3–1.6 mmHg, and had a short follow-up. The cross-sectional observation by Hauser et al. (3), although larger in sample size, had no controls, no dry eye disease diagnosis, and no causal inference. The positive results of all five cannot distinguish the fascial mechanical coupling claimed by this framework from nonspecific autonomic activation, broad acupuncture effects, expectation effects, composite intervention effects, or nonspecific blood flow responses to local procedures.
9.9. Lymphatic Pathway: Structural and Functional Presence Is Not Equivalent to Functional Change Under Mechanical Conditions
Clapham et al. (53), Struthoff et al. (49), and Keser et al. (54) jointly indicate that the lymphatic pathway has advanced from structural existence to in vivo functional existence, but alteration of drainage function under mechanical conditions—the link required after release of the investing fascia—remains entirely unmeasured.
9.10. Broad-Scope Structure of Prior Preprints
Preprint (13) was developed with dual cerebral–ocular endpoints and five parallel pathways; preprint (14) was anchored to the immediate effects of multi-node minimally invasive release and developed with three parallel pathways; and preprint (15) identified core gaps through a narrative review of six-system coupling. None of the three bears the logical burden that falsification of the single node H2 invalidates the entire chain, nor do they use sham-intervention control and ocular surface parallel-mechanism exclusion as attribution prerequisites (13,14,15). The narrowing of the present article is precisely intended to transform the release intervention hypothesis into a set of propositions that can be falsified item by item.
9.11. Competing Explanation of the Osseous Instability Hypothesis
The cervico-ocular hypothesis proposed by Hauser et al. takes abnormal cervical alignment as its upstream starting point and explains ocular symptoms through dynamic compression of the carotid sheath (4), and its cross-sectional observation also reported the coexistence of C1–C2 instability with carotid sheath structural abnormalities and ocular metrics (3). This article lists the osseous instability hypothesis in the framework as an upstream candidate parallel to fascial mechanical coupling. If future studies show that the association between investing fascial mechanical parameters and ocular surface metrics disappears after controlling for cervical structural variables, then the H4 subtype definition in this article needs to reconsider the possibility of osseous instability as a confounding or alternative explanation. Conversely, if the association persists after controlling for osseous variables, then the fascial level may constitute an independent upstream variable. In addition, the high heterogeneity of dry eye disease and comorbid confounding cannot be excluded within this framework. The possibility of reverse causation also cannot be excluded: ocular surface inflammation or pain may first mobilize cervical muscle and fascial tension.
10. Conclusions
This article has argued, from anatomical and mechanical perspectives, the mechanistic plausibility of release of the investing fascia as an intervention for subtypes of dry eye disease. Its core argument is that abnormal passive tension in the investing fascia and anterior cervical connective tissue network can be transmitted through a layer-specific network to the carotid sheath region, altering the mechanical microenvironment of the sheath wall and intrasheath structures. Release of this network can be expected to reduce this abnormal tension and, through the four groups of pathways—arterial perfusion, venous return, lymphatic drainage, and autonomic neural regulation—produce six types of downstream effects. The anatomical basis of this argument is the layer-specific description of sheath wall composition from adult cadaveric studies (9–12). Its mechanical basis is the continuous or tight connection between the anterior cervical connective tissue network and the sheath wall, the human in vivo order-of-magnitude reference of approximately 60%–90% transmission efficiency (41,42), and the precedent of SWE-measurable stiffness reduction after fascial hydrodissection (17). Its downstream-effect basis is the available indirect evidence for the four groups of pathways. Among these, the animal in vivo functional template for the autonomic neural dimension (57) provides only a possibility reference for the intermediate link, whose boundaries are given in Section 5.6.5 and Section 9.5 and which does not constitute evidence of mechanical sensitivity. However, the clinical efficacy of this argument has not yet been confirmed by controlled trials with clearly defined targets. The existing RCTs, network meta-analyses, single-arm studies, and pilot RCTs all involve composite interventions, unspecified targets, absence of controls, or mismatched populations and endpoints (31–34) and cannot be used for mechanistic attribution. Therefore, what this article argues is the mechanistic plausibility of release of the investing fascia as an intervention.
Throughout this article, a distinction is made among known anatomical and physiological facts, reasonable mechanical inferences, and intervention hypotheses yet to be validated. The inferences yet to be validated in this article are summarized in three categories. (1) Inferences related to the core coupling of H2, including the cross-layer transmission efficiency after release of the investing fascia, the spatial transmission from the anterior to the posterior sheath wall, and the causal relationship between sheath deformation and neural function. (2) Inferences related to molecular and cross-species or cross-tissue extrapolation, including the transduction function of the Piezo1–YAP axis at the investing fascial interface, extrapolation of macrophage PIEZO1 evidence to the sheath interface, the applicability of the Ca²⁺–hyaluronic acid parallel pathway, and extrapolation from various animal or ex vivo models to the human investing fascia. (3) Inferences related to downstream-effect attribution and competing explanations fall into several groups. These include causal attribution of the six-pathway spectrum; the in vivo mechanical consequences of intra-sheath variation of the cervical sympathetic trunk; population parameterization of the detection rate and positional variation of the middle cervical ganglion; cross-population applicability of vagus nerve cross-sectional area reference values; inference from the coexistence of carotid sheath structural abnormalities and ocular metrics to a causal relationship; distinction between the osseous instability hypothesis and the fascial mechanical coupling hypothesis; and the version relationship and incremental boundaries between the author's prior preprints (13,14,15) and this article. The item-by-item limitations of the above three categories of inferences have been annotated in Section 4.2, Section 5.5.3 and Section 5.6.7, and Section 9.1, Section 9.2, Section 9.3, Section 9.4, Section 9.5, Section 9.6, Section 9.7, Section 9.8, Section 9.9, Section 9.10 and Section 9.11 and are not repeated here. None should be cited as an established mechanism. The four-phase serial agenda proposed in Section 7.5 is a research design recommendation and does not constitute any completed evidence. What this article claims is merely that, from anatomical and mechanical perspectives, release of the investing fascia has a plausible mechanistic basis for intervening in dry eye disease subtypes, and that this mechanism can be tested by a measurement agenda that is falsified in a phased manner.
Author Contributions
Xuefeng Huang conceived and designed the hypothesis, conducted the literature synthesis, and drafted the manuscript. Xuefeng Huang is the sole author of this work and takes full responsibility for the integrity and accuracy of the content. The author reviewed and approved the final version of the manuscript.
Funding Statement
This work received no funding support.
Ethics Statement
This article is a theoretical hypothesis study; no human participants or animal experiments were performed. Therefore, no ethics approval was required. All cited data are derived from previously published literature.
Data Availability Statement
Data availability is not applicable to this article, as no new data were created or analyzed in this study. This article is a hypothesis paper that presents a theoretical framework and does not involve original experimental or clinical data.
AI-Assisted Writing Statement
During the preparation of this work, the author used AI language models (including but not limited to ChatGPT and DeepSeek) as auxiliary tools for literature retrieval and classification, visualization suggestions for the argumentation framework, and language expression optimization in certain sections. All AI-generated content was strictly reviewed, modified, and verified by the author, who takes full responsibility for all content of this article, including all scientific viewpoints, data interpretations, and conclusions. No AI tools were used to generate the core scientific hypotheses or original research data; all core arguments, mechanistic models, and testable predictions were independently proposed by the author.
Conflicts of Interest Statement
The author declares no conflicts of interest.
References
- Lian, L.; Ye, X.; Wang, Z.; Li, J.; Wang, J.; Chen, L.; et al. Hyperosmotic stress-induced NLRP3 inflammasome activation via the mechanosensitive PIEZO1 channel in dry eye corneal epithelium. Ocul. Surf. 2025, 36, 106–118. [Google Scholar] [CrossRef] [PubMed]
- Fukuoka, S.; Adachi, N.; Ouchi, E.; Ikemoto, H.; Okumo, T.; Ishikawa, F.; et al. Mechanoreceptor Piezo1 channel-mediated interleukin expression in conjunctival epithelial cells: Linking mechanical stress to ocular inflammation. Ocul. Surf. 2025, 36, 56–68, Erratum in: Ocul Surf. 2026, 41, 54. https://doi.org/10.1016/j.jtos.2026.05.001. [Google Scholar] [CrossRef] [PubMed]
- Hauser, R.A.; Griffiths, M.; Watterson, A.; Matias, D.; Rawlings, B. Objective test findings in patients with chronic eye symptoms seeking care at an outpatient neck center: ligamentous cervical instability etiology? Front Neurol. 2025, 16, 1576315. [Google Scholar] [CrossRef] [PubMed]
- Hauser, R.A.; Griffiths, M.; Matias, D.; Rawlings, B.R. Cervical Oculopathy: The Cervical Spine Etiology of Visual Symptoms and Eye Diseases-A Hypothesis Exploring Mechanisms Linking the Neck and the Eye. Diagnostics 2025, 15, 2650. [Google Scholar] [CrossRef] [PubMed]
- Pirri, C.; Pirri, N.; Petrelli, L.; De Caro, R.; Stecco, C. Redefining Fascia: A Mechanobiological Hub and Stem Cell Reservoir in Regeneration-A Systematic Review. Int. J. Mol. Sci. 2025, 26, 10166. [Google Scholar] [CrossRef] [PubMed]
- Miyake, N.; Hayashi, S.; Kawase, T.; Cho, B.H.; Murakami, G.; Fujimiya, M.; et al. Fetal anatomy of the human carotid sheath and structures in and around it. Anat. Rec. 2010, 293, 438–45. [Google Scholar] [CrossRef] [PubMed]
- Bond, J.D.; Zheng, F.; Wang, Q.; Zhang, M. The carotid sheath: Anatomy and clinical considerations. World Neurosurg. X 2023, 18, 100158. [Google Scholar] [CrossRef] [PubMed]
- Zhang, M.; Lee, A.S. The investing layer of the deep cervical fascia does not exist between the sternocleidomastoid and trapezius muscles. Otolaryngol. Head Neck Surg. 2002, 127, 452–4. [Google Scholar] [CrossRef] [PubMed]
- Nash, L.; Nicholson, H.D.; Zhang, M. Does the investing layer of the deep cervical fascia exist? Anesthesiology 2005, 103, 962–8. [Google Scholar] [CrossRef] [PubMed]
- Hayashi, S. Histology of the human carotid sheath revisited. Okajimas Folia Anat. Jpn. 2007, 84, 49–60. [Google Scholar] [CrossRef] [PubMed]
- Shan, J.L.; Jiang, H.; Li, F.; Sun, T.S.; Wang, L.Y. Anatomic relationship between prevertebral fascia and carotid sheath and its significance in the anterior cervical operation. Chin. J. Spine Spinal Cord. 2005, 8. [Google Scholar]
- Schachtel, M.J.C.; Gandhi, M.; Midwinter, M.J.; Panizza, B.J. Fascial layers encountered in the lateral skull base region: A cadaveric and radiological analysis. Head Neck 2023, 45, 1272–1280. [Google Scholar] [CrossRef] [PubMed]
- Huang, X. Investing Fascia Tension as a Potential Mechanical Node in Cerebral Hypoperfusion and Ocular Pathology: A Mechanistic Hypothesis with Quantitative Predictions and a Multi-Scale Validation Framework. 2026. [Google Scholar] [CrossRef]
- Huang, X. Immediate effects of multi-node minimally invasive release of the investing fascia in the treatment of dry eye: a mechanoneural coupling hypothesis [Preprint]. Zenodo 2026. [Google Scholar] [CrossRef]
- Huang, X. Increased Neck Circumference and Altered Cervical Fascial Mechanics: Rehabilitation Implications of a Six-System Coupling Framework for the Carotid Sheath—A Narrative Review [Preprint]. Preprints.org. 2026. [Google Scholar] [CrossRef]
- Zhao, H.X.; Zhou, H.D.; Wei, Y.; Zhao, Z.L.; Peng, L.L.; Li, Y.; et al. Development of a Three-Layered Fascial Architecture in the Rabbit Carotid Sheath: Histological Findings Consistent With Mechanical Influences. Anat. Histol. Embryol. 2026, 55, e70170. [Google Scholar] [CrossRef] [PubMed]
- Nakao, G.; Shiwaku, K.; Adachi, R.; Kodesho, T.; Taniguchi, K.; Otsubo, H. Effects of hydrorelease on the mechanical properties of muscle and fascia: A study using ultrasonic shear wave elastography. Clin. Physiol. Funct. Imaging 2026, 46, e70052. [Google Scholar] [CrossRef] [PubMed]
- Prabu Raja, G.; Shyamasunder Bhat, N.; Marie Cruz, A.; Prabhu, A.; Fernandes, S.; Naaz, N. The anatomical myofascial continuum between the neck and eyes. Clin. Anat. 2022, 35, 340–346. [Google Scholar] [CrossRef] [PubMed]
- Tu, S.; Li, Y.; Li, J.; Ma, N.; Yao, K.; Chen, Z.; et al. Mechanical stretch-mediated fibroblast activation: The pivotal role of Piezo1 channels. Biochim Biophys. Acta Mol. Cell Res. 2025, 1872, 120008. [Google Scholar] [CrossRef] [PubMed]
- Xu, L.; Li, T.; Cao, Y.; He, Y.; Shao, Z.; Liu, S.; et al. PIEZO1 mediates periostin+ myofibroblast activation and pulmonary fibrosis in mice. J. Clin. Invest. 2025, 135, e184158. [Google Scholar] [CrossRef] [PubMed]
- Huang, Y.; Song, Z.; Mei, X.; Zhao, Y.; Zhu, T.; Shi, M.; et al. Piezo1 drives fibroblast activation in epidural fibrotic remodelling via the ET-1/HIF-1α pathway. Bone Jt. Res. 2026, 15, 1017–1032. [Google Scholar] [CrossRef] [PubMed]
- Konishi, T.; Kamiyama, K.; Osato, T.; Yoshimoto, T.; Aoki, T.; Anzai, T.; et al. Increased Piezo1 expression in myofibroblasts in patients with symptomatic carotid atherosclerotic plaques undergoing carotid endarterectomy: A pilot study. Vascular 2024, 32, 1063–1069. [Google Scholar] [CrossRef] [PubMed]
- Alba, E.; García-Mesa, Y.; Cobo, R.; Cuendias, P.; Martín-Cruces, J.; Suazo, I.; et al. Immunohistochemical Detection of PIEZO Ion Channels in the Human Carotid Sinus and Carotid Body. Biomolecules 2025, 15, 386. [Google Scholar] [CrossRef] [PubMed]
- Tu, S.W.; Kawanokuchi, J.; Takagi, K.; Liu, Y.Y.; Li, J.Y.; Deng, K.Y.; et al. Fibroblasts as key effectors of acupuncture in treatment of rheumatoid arthritis. Front Immunol. 2026, 17, 1715313. [Google Scholar] [CrossRef] [PubMed]
- He, J.; Fang, B.; Shan, S.; Xie, Y.; Wang, C.; Zhang, Y.; et al. Mechanical stretch promotes hypertrophic scar formation through mechanically activated cation channel Piezo1. Cell Death Dis. 2021, 12, 226. [Google Scholar] [CrossRef] [PubMed]
- Li, K.; Wei, P.; Li, Z.; Kuang, W.; Zhang, M.; Luo, C.; et al. Hydrostatic pressure regulates glutamine metabolism to promote bladder fibroblast activation via the Piezo1/YAP1/GLS1 axis. J. Transl. Med. 2026, 24, 418. [Google Scholar] [CrossRef] [PubMed]
- Liao, C.; Wang, P.; Zeng, Q.; Yan, G.; Gao, J.; Liu, J.; et al. Piezo1-Mediated Calcium Flux Transfers Mechanosignal to Yes-Associated Protein to Stimulate Matrix Production in Keloid. J. Invest Dermatol. 2025, 145, 2869–2881.e9. [Google Scholar] [CrossRef] [PubMed]
- Wei, Y.; Xie, C.; Yang, X.; Tang, X.X. The PIEZO1/CISD1/IP3R Mechanotransduction Axis Drives Macrophage Mitochondrial Dysfunction and Inflammatory Activation in Pulmonary Fibrosis. MedComm (2020) 2026, 7, e71080. [Google Scholar] [CrossRef] [PubMed]
- Atcha, H.; Kulkarni, D.; Meli, V.S.; Veerasubramanian, P.K.; Wang, Y.; Cahalan, M.D.; et al. Piezo1-mediated mechanotransduction enhances macrophage oxidized low-density lipoprotein uptake and atherogenesis. PNAS Nexus 2024, 3, pgae436. [Google Scholar] [CrossRef] [PubMed]
- Shen, T.; Wang, T.; Wu, L.; Wang, Z.; Gan, L.; Luo, Y.; et al. Tissue-Resident Macrophage PIEZO1 Transduces Mechanical Stress into Inflammatory Pain in Acute Gout. Neurosci. Bull. 2026, 42, 1521–1535. [Google Scholar] [CrossRef] [PubMed]
- Zhang, J.W.; Liu, N.G. Effect of needle-knife as adjunctive therapy on dry eye syndrome. Zhongguo Zhen Jiu 2020, 40, 731–5. (In Chinese) [Google Scholar] [CrossRef] [PubMed]
- Yan, X.; Hu, J.; Chen, Y.; Lei, S.; Chen, J.; Qin, M. A Network Meta-Analysis Comparing the Efficacy Differences of Different Acupuncture and Sodium Hyaluronate Eye Drops in the Treatment of Dry Eye Disease. J. Pain Res. 2026, 19, 577237. [Google Scholar] [CrossRef] [PubMed]
- Hiroki, T.; Kimura, H.; Kobayashi, T.; Horigome, H.; Suda, M.; Fukui, S.; et al. The analgesic effect of ultrasound-guided fascia hydrorelease around the artery for myofascial neck pain: a prospective single-arm interventional study. PLoS ONE 2026, 21, e0350882. [Google Scholar] [CrossRef] [PubMed]
- King, H.H.; Weinreb, R.N.; Walker, E.; Zangwill, L.M. Effects of a single osteopathic manipulative treatment on intraocular pressure reduction: a pilot study. J. Osteopath Med. 2025, 125, 351–358. [Google Scholar] [CrossRef] [PubMed]
- Oura, K.; Akasaka, H.; Ishizuka, N.; Sato, Y.; Kudo, M.; Yamaguchi, T.; et al. Ultrasound evaluation of vagus nerve cross-sectional area in a community-dwelling elderly Japanese cohort. PLoS ONE 2023, 18, e0280661. [Google Scholar] [CrossRef] [PubMed]
- Bedewi, M.A.; Kotb, M.A.; Almalki, D.M.; AlAseeri, A.A.; Sandougah, K.J.; Abdelnaby, R.; et al. Ultrasound of the normal vagus nerve cross-sectional area in the carotid sheath. Medicine 2023, 102, e33996. [Google Scholar] [CrossRef] [PubMed]
- Fisse, A.L.; Katsanos, A.H.; Gold, R.; Pitarokoili, K.; Krogias, C. Cross-sectional area reference values for peripheral nerve ultrasound in adults: A systematic review and meta-analysis-Part III: Cervical nerve roots and vagal nerve. Eur. J. Neurol. 2021, 28, 2319–2326. [Google Scholar] [CrossRef] [PubMed]
- Pires, S.; Freitas, M.; Pinho, F.; Brandão, S. Mechanosensitivity and Adipose Thickness as Determinants of Pressure to Reach Deep Fasciae in Cervical and Thoracolumbar Regions. Sensors 2025, 25, 5073. [Google Scholar] [CrossRef] [PubMed]
- Liao, L.R.; Pan, H.H.; Diao, Y.X.; Xie, Y.; Liao, M.X.; Xie, Y.H. Reliability of shear-wave elastography in assessing the stiffness of the nuchal fascia and the thickness of upper cervical muscles. Med. Eng. Phys. 2023, 120, 104039. [Google Scholar] [CrossRef] [PubMed]
- Zandi, S.; Mokhtarinia, H.R.; Mosallanezhad, Z.; Mobin, H.K.; Arab, A.M.; Azadi, F.; et al. Reliability of shear wave elastography for cervical and lumbar fascia stiffness and thickness in healthy and chronic neck and low back pain subjects. J. Bodyw. Mov. Ther. 2025, 42, 558–566. [Google Scholar] [CrossRef] [PubMed]
- Querry, R.G.; Smith, S.A.; Strømstad, M.; Ide, K.; Secher, N.H.; Raven, P.B. New Collective Author. Anatomical and functional characteristics of carotid sinus stimulation in humans. Am. J. Physiol. Heart Circ. Physiol. 2001, 280, H2390–8. [Google Scholar] [CrossRef] [PubMed]
- Ludbrook, J.; Mancia, G.; Ferrari, A.; Zanchetti, A. The variable-pressure neck-chamber method for studying the carotid baroreflex in man. Clin. Sci. Mol. Med. 1977, 53, 165–71. [Google Scholar] [CrossRef] [PubMed]
- Shen, J.; Xie, R.; Yang, T.; Dong, S.; Zhen, Y.; Yang, L.; et al. Ion Channels and Dry Eye Disease: From Physiological Functions to Targeted Therapeutic Mechanisms. FASEB J. 2026, 40, e72103. [Google Scholar] [CrossRef] [PubMed]
- Kiray, A.; Arman, C.; Naderi, S.; Güvencer, M.; Korman, E. Surgical anatomy of the cervical sympathetic trunk. Clin. Anat. 2005, 18, 179–85. [Google Scholar] [CrossRef] [PubMed]
- Chen, M.; Tang, H.; Shan, J. Anatomic relationship between the cervical sympathetic trunk and cervical fascia and its application in the anterolateral cervical spine surgical approach. Eur. Spine J. 2021, 30, 425–430. [Google Scholar] [CrossRef] [PubMed]
- Park, C.; Suh, C.H.; Shin, J.E.; Baek, J.H. Characteristics of the Middle Cervical Sympathetic Ganglion: A Systematic Review and Meta-Analysis. Pain Physician 2018, 21, 9–18. [Google Scholar] [CrossRef] [PubMed]
- Yin, Z.; Yin, J.; Cai, J.; Sui, T.; Cao, X. Neuroanatomy and clinical analysis of the cervical sympathetic trunk and longus colli. J. BioMed Res. 2015, 29, 501–7. [Google Scholar] [CrossRef] [PubMed]
- Lyons, A.J.; Mills, C.C. Anatomical variants of the cervical sympathetic chain to be considered during neck dissection. Br. J. Oral Maxillofac. Surg. 1998, 36, 180–2. [Google Scholar] [CrossRef] [PubMed]
- Struthoff, H.; Lauder, L.; Federspiel, J.M.; Hohl, M.; Böhm, M.; Tschernig, T.; et al. Human nerve distribution and density around the carotid artery bifurcation. Clin. Res. Cardiol. 2024, 113, 1508–1513. [Google Scholar] [CrossRef] [PubMed]
- Yang, H.; Hou, X.; Ye, L.; He, Y.; Chen, W.; Tao, X. Macrophage-fibroblast communication driven by biomechanical stress in the pulmonary profibrotic niche: From signalling transduction to clinical translation. Cells Dev. 2026, 188, 204113. [Google Scholar] [CrossRef] [PubMed]
- Kirkness, K.B.; Scarlata, S. Understanding Fascial Tissue on the Molecular Level-How Its Unique Properties Enable Adaptation or Dysfunction. Int. J. Mol. Sci. 2025, 27, 160. [Google Scholar] [CrossRef] [PubMed]
- Li, C.; Yue, C.; Liu, Z.C.; Gong, J.; Wei, X.S.; Yang, H.; et al. The relationship between myodural bridges, hyperplasia of the suboccipital musculature, and intracranial pressure. PLoS ONE 2022, 17, e0273193. [Google Scholar] [CrossRef] [PubMed]
- Clapham, R.; O'Sullivan, E.; Weller, R.O.; Carare, R.O. Cervical lymph nodes are found in direct relationship with the internal carotid artery: significance for the lymphatic drainage of the brain. Clin. Anat. 2010, 23, 43–7. [Google Scholar] [CrossRef] [PubMed]
- Keser, Z.; Smith, G.; Cagil, E.; Tufan, F.; Albayram, O.; Albayram, M.S. High-resolution MRI to noninvasively characterize drainage around the carotid artery into the cervical lymph nodes. J. Neuroimaging 2023, 33, 102–108. [Google Scholar] [CrossRef] [PubMed]
- Yan, M.; Cheng, L.; Zheng, Z.; Lin, Y.; Qin, D.; Chen, H. Advances in the Understanding of ocular and nasal lymphatics. BMC Immunol. 2025, 26, 16. [Google Scholar] [CrossRef] [PubMed]
- Mo, X.; Meng, H.; Wu, Y.; Yang, S.; Zhang, Y.; Zhou, Y. Measurement of lacrimal gland tissue stiffness for the diagnosis of visual display terminal-associated dry eye disease using shear wave elastography. Heliyon 2024, 10, e33912. [Google Scholar] [CrossRef] [PubMed]
- Abe, S.; Karita, K.; Izumi, H.; Nakanome, Y.; Okabe, H.; Tamai, M. Experimental research on choroidal circulation. 1. Effect of sectioning or stimulation of the cervical sympathetic nerve upon choroidal blood flow. Nippon Ganka Gakkai Zasshi 1993, 97, 494–500. (In Japanese) [Google Scholar]
- Sadeghi, S.; Cortes, D.H. Measurement of the shear modulus in thin-layered tissues using numerical simulations and shear wave elastography. J. Mech. Behav. BioMed Mater. 2020, 102, 103502. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.